Richard Morgan - Publications

Affiliations: 
St. George's Hospital, London, London, England, United Kingdom 
Area:
Neuronal development

1/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Morgan R, Fairfax B, Pandha HS. Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK. Molecular Cancer. 5: 51. PMID 17078869 DOI: 10.1186/1476-4598-5-51  0.53
Low-probability matches (unlikely to be authored by this person)
2014 Abate-Daga D, Speiser DE, Chinnasamy N, Zheng Z, Xu H, Feldman SA, Rosenberg SA, Morgan RA. Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer. Plos One. 9: e93321. PMID 24681846 DOI: 10.1371/journal.pone.0093321  0.24
2012 Morgan RA, Johnson LA, Davis JL, Zheng Z, Woolard KD, Reap EA, Feldman SA, Chinnasamy N, Kuan CT, Song H, Zhang W, Fine HA, Rosenberg SA. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Human Gene Therapy. 23: 1043-53. PMID 22780919 DOI: 10.1089/hum.2012.041  0.231
2014 Rosati SF, Parkhurst MR, Hong Y, Zheng Z, Feldman SA, Rao M, Abate-Daga D, Beard RE, Xu H, Black MA, Robbins PF, Schrump DA, Rosenberg SA, Morgan RA. A novel murine T-cell receptor targeting NY-ESO-1. Journal of Immunotherapy (Hagerstown, Md. : 1997). 37: 135-46. PMID 24598449 DOI: 10.1097/CJI.0000000000000019  0.231
2009 Burns WR, Zheng Z, Rosenberg SA, Morgan RA. Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation. Blood. 114: 2888-99. PMID 19589923 DOI: 10.1182/blood-2009-01-199216  0.228
2008 Theoret MR, Cohen CJ, Dudley ME, Morgan RA, Rosenberg SA. In vitro and in vivo studies of human lymphocytes genetically engineered to express T cell receptors that recognize a p53 antigenic epitope. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3032. PMID 27947569 DOI: 10.1200/jco.2008.26.15_suppl.3032  0.227
2009 Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood. 114: 535-46. PMID 19451549 DOI: 10.1182/Blood-2009-03-211714  0.226
2015 Lilley G, Ladd A, Cossette D, Viggiano L, Hopkins G, Evans JW, Li M, Latimer HJ, Miller SM, Kuczewski M, Bakeman W, MacLeod K, Friedman KM, Maier DA, Paglia M, ... Morgan RA, et al. Characterization of Lentiviral Vector Derived Anti-Bcma CAR T Cells Reveals Key Parameters for Robust Manufacturing of Cell-Based Gene Therapies for Multiple Myeloma Blood. 126: 3243-3243. DOI: 10.1182/BLOOD.V126.23.3243.3243  0.225
2018 Friedman KM, Garrett TE, Evans JW, Horton HM, Latimer HJ, Seidel SL, Horvath CJ, Morgan RA. Effective Targeting of Multiple BCMA-Expressing Hematological Malignancies by Anti-BCMA CAR T Cells. Human Gene Therapy. PMID 29641319 DOI: 10.1089/hum.2018.001  0.223
2015 Chekmasova AA, Horton HM, Garrett TE, Evans JW, Griecci J, Hamel A, Latimer HJ, Seidel SL, Ryu BY, Kuczewski M, Horvath CJ, Friedman KM, Morgan RA. A Novel and Highly Potent CAR T Cell Drug Product for Treatment of BCMA-Expressing Hematological Malignances Blood. 126: 3094-3094. DOI: 10.1182/BLOOD.V126.23.3094.3094  0.223
2008 Theoret MR, Cohen CJ, Nahvi AV, Ngo LT, Suri KB, Powell DJ, Dudley ME, Morgan RA, Rosenberg SA. Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells. Human Gene Therapy. 19: 1219-32. PMID 19848582 DOI: 10.1089/HUM.2008.083  0.219
2015 Robbins PF, Kassim SH, Tran TL, Crystal JS, Morgan RA, Feldman SA, Yang JC, Dudley ME, Wunderlich JR, Sherry RM, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, et al. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1019-27. PMID 25538264 DOI: 10.1158/1078-0432.Ccr-14-2708  0.217
2007 Zhao Y, Parkhurst MR, Zheng Z, Cohen CJ, Riley JP, Gattinoni L, Restifo NP, Rosenberg SA, Morgan RA. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Research. 67: 2425-9. PMID 17363559 DOI: 10.1158/0008-5472.Can-06-3977  0.216
2013 Abate-Daga D, Hanada K, Davis JL, Yang JC, Rosenberg SA, Morgan RA. Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes. Blood. 122: 1399-410. PMID 23861247 DOI: 10.1182/blood-2013-04-495531  0.214
2012 Zhang L, Morgan RA. Genetic engineering with T cell receptors. Advanced Drug Delivery Reviews. 64: 756-62. PMID 22178904 DOI: 10.1016/j.addr.2011.11.009  0.211
1994 Couture LA, Mullen CA, Morgan RA. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression. Human Gene Therapy. 5: 667-77. PMID 7948129 DOI: 10.1089/hum.1994.5.6-667  0.211
2010 Davis JL, Theoret MR, Zheng Z, Lamers CH, Rosenberg SA, Morgan RA. Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5852-61. PMID 21138872 DOI: 10.1158/1078-0432.CCR-10-1280  0.21
2005 Hughes MS, Yu YY, Dudley ME, Zheng Z, Robbins PF, Li Y, Wunderlich J, Hawley RG, Moayeri M, Rosenberg SA, Morgan RA. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Human Gene Therapy. 16: 457-72. PMID 15871677 DOI: 10.1089/hum.2005.16.457  0.209
2008 Yang S, Rosenberg SA, Morgan RA. Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 830-9. PMID 18833004 DOI: 10.1097/CJI.0b013e31818817c5  0.208
2010 Morgan RA, Dudley ME, Rosenberg SA. Adoptive cell therapy: genetic modification to redirect effector cell specificity. Cancer Journal (Sudbury, Mass.). 16: 336-41. PMID 20693844 DOI: 10.1097/PPO.0b013e3181eb3879  0.206
1991 Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proceedings of the National Academy of Sciences of the United States of America. 88: 3155-9. PMID 2014235 DOI: 10.1073/Pnas.88.8.3155  0.205
2006 Hsu C, Rosenberg S, Morgan R. 979. Clonal Expansion of a CD8+ T Cell Clone after Retroviral Transduction of Mature T Lymphocytes with the IL-15 Gene Molecular Therapy. 13: S376-S377. DOI: 10.1016/j.ymthe.2006.08.1072  0.203
2010 Burns WR, Zhao Y, Frankel TL, Hinrichs CS, Zheng Z, Xu H, Feldman SA, Ferrone S, Rosenberg SA, Morgan RA. A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Research. 70: 3027-33. PMID 20395199 DOI: 10.1158/0008-5472.Can-09-2824  0.203
2016 Yuen HF, Chan KK, Platt-Higgins A, Dakir EH, Matchett KB, Haggag YA, Jithesh PV, Habib T, Faheem A, Dean FA, Morgan R, Rudland PS, El-Tanani M. Ran GTPase promotes cancer progression via Met receptormediated downstream signaling. Oncotarget. PMID 27716616 DOI: 10.18632/Oncotarget.12420  0.203
2008 Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, Yu Z, Zheng Z, Jones S, Restifo NP, Rosenberg SA, Morgan RA. Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Therapy. 15: 1411-23. PMID 18496571 DOI: 10.1038/Gt.2008.90  0.202
2005 Cohen CJ, Zheng Z, Bray R, Zhao Y, Sherman LA, Rosenberg SA, Morgan RA. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. Journal of Immunology (Baltimore, Md. : 1950). 175: 5799-808. PMID 16237072 DOI: 10.4049/Jimmunol.175.9.5799  0.202
2011 Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DN, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, et al. T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 620-626. PMID 28160822 DOI: 10.1038/mt.2010.272  0.202
2011 Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 620-6. PMID 21157437 DOI: 10.1038/Mt.2010.272  0.202
2006 Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science (New York, N.Y.). 314: 126-9. PMID 16946036 DOI: 10.1126/Science.1129003  0.201
2007 Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, Robbins PF, Peng PD, Shen X, Gomes TJ, Dunbar CE, Munroe DJ, Stewart C, Cornetta K, Wangsa D, ... Morgan RA, et al. Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood. 109: 5168-77. PMID 17353346 DOI: 10.1182/Blood-2006-06-029173  0.201
2021 Zhang L, Zuris JA, Viswanathan R, Edelstein JN, Turk R, Thommandru B, Rube HT, Glenn SE, Collingwood MA, Bode NM, Beaudoin SF, Lele S, Scott SN, Wasko KM, Sexton S, ... ... Morgan RA, et al. AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines. Nature Communications. 12: 3908. PMID 34162850 DOI: 10.1038/s41467-021-24017-8  0.201
2006 Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 151-9. PMID 16140584 DOI: 10.1016/J.Ymthe.2005.07.688  0.2
2005 Zhao Y, Zheng Z, Robbins PF, Khong HT, Rosenberg SA, Morgan RA. Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. Journal of Immunology (Baltimore, Md. : 1950). 174: 4415-23. PMID 15778407 DOI: 10.4049/Jimmunol.174.7.4415  0.2
1998 Onodera M, Nelson DM, Yachie A, Jagadeesh GJ, Bunnell BA, Morgan RA, Blaese RM. Development of improved adenosine deaminase retroviral vectors. Journal of Virology. 72: 1769-74. PMID 9499026 DOI: 10.1128/Jvi.72.3.1769-1774.1998  0.2
2010 Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 843-51. PMID 20179677 DOI: 10.1038/mt.2010.24  0.2
2007 Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, Morgan RA. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Research. 67: 3898-903. PMID 17440104 DOI: 10.1158/0008-5472.CAN-06-3986  0.199
2011 Park TS, Rosenberg SA, Morgan RA. Treating cancer with genetically engineered T cells. Trends in Biotechnology. 29: 550-7. PMID 21663987 DOI: 10.1016/j.tibtech.2011.04.009  0.199
2013 Abate-Daga D, Lagisetty KH, Gattinoni L, Yu Z, Restifo NP, Rosenberg SA, Morgan RA. Abstract 3966: Development of a fully-human chimeric antigen receptor against PSCA for the treatment of pancreatic cancer. Cancer Research. 73: 3966-3966. DOI: 10.1158/1538-7445.Am2013-3966  0.198
1991 Morgan RA, Cornetta K, Anderson WF. Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Human Gene Therapy. 1: 135-49. PMID 1964093 DOI: 10.1089/HUM.1990.1.2-135  0.198
2013 Li Z, Zhang Z, Li Y, Arnovitz S, Chen P, Huang H, Jiang X, Hong GM, Kunjamma RB, Ren H, He C, Wang CZ, Elkahloun AG, Valk PJ, Döhner K, ... ... Morgan R, et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood. 121: 1422-31. PMID 23264595 DOI: 10.1182/Blood-2012-07-442004  0.198
2012 Yang S, Karne NK, Goff SL, Black MA, Xu H, Bischof D, Cornetta K, Rosenberg SA, Morgan RA, Feldman SA. A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytes. Human Gene Therapy Methods. 23: 73-83. PMID 22515320 DOI: 10.1089/Hgtb.2011.199  0.197
2011 Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP. Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 343-52. PMID 21499127 DOI: 10.1097/Cji.0B013E3182187600  0.196
2009 Peng PD, Cohen CJ, Yang S, Hsu C, Jones S, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Therapy. 16: 1042-9. PMID 19494842 DOI: 10.1038/gt.2009.54  0.196
2014 Abate-Daga D, Lagisetty KH, Tran E, Zheng Z, Gattinoni L, Yu Z, Burns WR, Miermont AM, Teper Y, Rudloff U, Restifo NP, Feldman SA, Rosenberg SA, Morgan RA. A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer. Human Gene Therapy. 25: 1003-12. PMID 24694017 DOI: 10.1089/Hum.2013.209  0.196
2010 Goff SL, Johnson LA, Black MA, Xu H, Zheng Z, Cohen CJ, Morgan RA, Rosenberg SA, Feldman SA. Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion. Cancer Immunology, Immunotherapy : Cii. 59: 1551-60. PMID 20628878 DOI: 10.1007/s00262-010-0882-5  0.196
2007 Jorritsma A, Gomez-Eerland R, Dokter M, Kasteele Wvd, Zoet YM, Doxiadis IIN, Rufer N, Romero P, Morgan RA, Schumacher TNM, Haanen JBAG. Selecting highly affine and well-expressed TCRs for gene therapy of melanoma. Blood. 110: 3564-3572. PMID 17660381 DOI: 10.1182/Blood-2007-02-075010  0.196
2018 Hooper K, Havens K, Krostag A, Magee MS, Martin U, Gupta A, Smurnyy Y, Pechilis L, Rode A, Chavkin A, Grande S, Morgan RA, Jarjour J, Astrakhan A. Knockout of CBLB Greatly Enhances Anti-Tumor Activity of CAR T Cells Blood. 132: 338-338. DOI: 10.1182/BLOOD-2018-99-119247  0.195
2011 Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 917-24. PMID 21282551 DOI: 10.1200/Jco.2010.32.2537  0.194
2020 Wong K, Sexton S, Donahue K, Antony LP, Wasko K, Nasser J, Leary G, Pfautz A, Porth O, Pierce W, Sousa P, Scott S, Wilson A, Chang K, Zuris J, ... ... Morgan R, et al. 145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment Journal For Immunotherapy of Cancer. 8: A158-A158. DOI: 10.1136/jitc-2020-sitc2020.0145  0.194
2012 Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. The American Journal of Surgical Pathology. 36: 173-84. PMID 22251937 DOI: 10.1097/PAS.0b013e3182417d36  0.194
2008 Abad JD, Wrzensinski C, Overwijk W, De Witte MA, Jorritsma A, Hsu C, Gattinoni L, Cohen CJ, Paulos CM, Palmer DC, Haanen JB, Schumacher TN, Rosenberg SA, Restifo NP, Morgan RA. T-cell receptor gene therapy of established tumors in a murine melanoma model. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 1-6. PMID 18157006 DOI: 10.1097/Cji.0B013E31815C193F  0.193
2017 Alharbi RA, Pandha HS, Simpson GR, Pettengell R, Poterlowicz K, Thompson A, Harrington K, El-Tanani M, Morgan R. Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. Oncotarget. 8: 89566-89579. PMID 29163771 DOI: 10.18632/oncotarget.20023  0.193
2010 Chinnasamy D, Yu Z, Theoret MR, Zhao Y, Shrimali RK, Morgan RA, Feldman SA, Restifo NP, Rosenberg SA. Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. The Journal of Clinical Investigation. 120: 3953-68. PMID 20978347 DOI: 10.1172/Jci43490  0.193
2011 Kochenderfer JN, Dudley ME, Feldman S, Wilson WH, Spaner D, Devillier L, Carpenter R, Nathan DN, Maric I, Morgan RA, Rosenberg SA. B-Cell Depletion, Remissions of Malignancy, and Cytokine-Associated Toxicity in a Clinical Trial of T Cells Genetically-Engineered to Express An Anti-CD19 Chimeric Antigen Receptor Blood. 118: 167-167. DOI: 10.1182/Blood.V118.21.167.167  0.193
2013 Abate-Daga D, Alexander TA, Arons E, Ho M, Robbins PF, Rosenberg SA, Morgan RA. Melanoma-associated B cells are distinct from peripheral blood-derived B cells, and may serve as a source of tumor-targeting antibodies Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P180  0.191
2020 Moon J, Chin MS, Burden AT, Sexton S, Wasko K, Nasser JM, Antony LP, Wong KK, Borges CM, Morgan RA, Welstead GG. Generation of Natural Killer Cells with Enhanced Function from a CRISPR/Cas12a-Edited Induced Pluripotent Stem Cell Line Blood. 136: 8-8. DOI: 10.1182/BLOOD-2020-139471  0.191
2008 Shears L, Plowright L, Harrington K, Pandha HS, Morgan R. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. The Journal of Urology. 180: 2196-201. PMID 18804814 DOI: 10.1016/j.juro.2008.07.018  0.19
2020 Morgan R, Pandha HS. PBX3 in Cancer. Cancers. 12. PMID 32069812 DOI: 10.3390/cancers12020431  0.19
2015 Iglesias JM, Cairney CJ, Ferrier RK, McDonald L, Soady K, Kendrick H, Pringle MA, Morgan RO, Martin F, Smalley MJ, Blyth K, Stein T. Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium. Plos One. 10: e0119718. PMID 25803307 DOI: 10.1371/journal.pone.0119718  0.19
1996 Chuah MK, VandenDriessche T, Morgan RA. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. Human Gene Therapy. 6: 1363-77. PMID 8573610 DOI: 10.1089/HUM.1995.6.11-1363  0.189
2010 Kochenderfer JN, Dudley ME, Stetler-Stevenson M, Wilson WH, Janik JE, Nathan DN, Maric I, Raffeld M, Feldman SA, Morgan RA, Rosenberg SA. A Phase I Clinical Trial of Treatment of B-Cell Malignancies with Autologous Anti-CD19-CAR-Transduced T Cells Blood. 116: 2865-2865. DOI: 10.1182/BLOOD.V116.21.2865.2865  0.189
2006 Johnson LA, Heemskerk B, Powell DJ, Cohen CJ, Morgan RA, Dudley ME, Robbins PF, Rosenberg SA. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 177: 6548-59. PMID 17056587 DOI: 10.4049/Jimmunol.177.9.6548  0.189
2019 Punia N, Primon M, Simpson GR, Pandha HS, Morgan R. Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma. Scientific Reports. 9: 5138. PMID 30914795 DOI: 10.1038/s41598-019-41678-0  0.189
1996 Mullen CA, Snitzer K, Culver KW, Morgan RA, Anderson WF, Blaese RM. Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector. Human Gene Therapy. 7: 1123-9. PMID 8773514 DOI: 10.1089/Hum.1996.7.9-1123  0.188
2019 Goff SL, Morgan RA, Yang JC, Sherry RM, Robbins PF, Restifo NP, Feldman SA, Lu YC, Lu L, Zheng Z, Xi L, Epstein M, McIntyre LS, Malekzadeh P, Raffeld M, et al. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 30882547 DOI: 10.1097/Cji.0000000000000260  0.188
2006 Zhao Y, Zheng Z, Cohen CJ, Rosenberg SA, Morgan RA. 454. Recognition of Tumor Antigens by In Vitro Developed T Cells from Hematopoietic Stem Cells Retrovirally Transduced with TCR Genes Molecular Therapy. 13: S175. DOI: 10.1016/j.ymthe.2006.08.522  0.188
2012 Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, ... ... Morgan R, et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature. 486: 266-70. PMID 22699621 DOI: 10.1038/Nature11114  0.188
2016 Kelly Z, Moller-Levet C, McGrath S, Butler-Manuel S, Kierzek AM, Pandha H, Morgan R, Michael A, Madhuri TK. The prognostic significance of specific HOX gene expression patterns in ovarian cancer. International Journal of Cancer. PMID 27225067 DOI: 10.1002/ijc.30204  0.187
2013 Tran E, Chinnasamy D, Yu Z, Morgan RA, Lee CC, Restifo NP, Rosenberg SA. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. The Journal of Experimental Medicine. 210: 1125-35. PMID 23712432 DOI: 10.1084/Jem.20130110  0.187
2006 Zhao Y, Zheng Z, Khong HT, Rosenberg SA, Morgan RA. Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 398-406. PMID 16799335 DOI: 10.1097/01.cji.0000203082.20365.7f  0.186
2022 Morgan R, Hunter K, Pandha HS. Downstream of the HOX genes: explaining conflicting tumour suppressor and oncogenic functions in cancer. International Journal of Cancer. PMID 35080776 DOI: 10.1002/ijc.33949  0.186
2004 Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. 186. Phenotypic Correction of Hemophilic Mice Using Hematopoietic Stem Cells Transduced with an MSCV-Based Oncoretroviral Vector Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.145  0.186
2014 Beard RE, Zheng Z, Lagisetty KH, Burns WR, Tran E, Hewitt SM, Abate-Daga D, Rosati SF, Fine HA, Ferrone S, Rosenberg SA, Morgan RA. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells. Journal For Immunotherapy of Cancer. 2: 25. PMID 25197555 DOI: 10.1186/2051-1426-2-25  0.186
2015 Vieira GC, Chockalingam S, Melegh Z, Greenhough A, Malik S, Szemes M, Park JH, Kaidi A, Zhou L, Catchpoole D, Morgan R, Bates DO, Gabb PD, Malik K. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. Oncotarget. PMID 26517508 DOI: 10.18632/Oncotarget.5548  0.185
2020 Borges CM, Wasko K, Nasser JM, Donahue K, Pfautz A, Antony LP, Leary G, Sexton S, Morgan RA, Wong KK. Preclinical Development of Edit-201, a Multigene Edited Healthy Donor NK Cell with Enhanced Anti-Tumor Function and Superior Serial Killing Activity in an Immunosuppressive Environment Blood. 136: 33-33. DOI: 10.1182/blood-2020-139988  0.185
2017 Berdeja JG, Lin Y, Raje N, Munshi N, Siegel D, Liedtke M, Jagannath S, Maus MV, Turka A, Lam LP, Hege K, Morgan RA, Quigley MT, Kochenderfer JN. Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy Blood. 130: 740-740. DOI: 10.1182/Blood.V130.Suppl_1.740.740  0.185
2009 Kochenderfer JN, Feldman SA, Zhao Y, Xu H, Black MA, Morgan RA, Wilson WH, Rosenberg SA. Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 689-702. PMID 19561539 DOI: 10.1097/CJI.0b013e3181ac6138  0.185
2013 Patel K, Scrimieri F, Ghosh S, Zhong J, Kim MS, Ren YR, Morgan RA, Iacobuzio-Donahue CA, Pandey A, Kern SE. FAM190A deficiency creates a cell division defect. The American Journal of Pathology. 183: 296-303. PMID 23665203 DOI: 10.1016/J.Ajpath.2013.03.020  0.184
2011 Hinrichs CS, Borman ZA, Gattinoni L, Yu Z, Burns WR, Huang J, Klebanoff CA, Johnson LA, Kerkar SP, Yang S, Muranski P, Palmer DC, Scott CD, Morgan RA, Robbins PF, et al. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood. 117: 808-14. PMID 20971955 DOI: 10.1182/Blood-2010-05-286286  0.184
2016 Morgan RA, Boyerinas B. Genetic Modification of T Cells. Biomedicines. 4. PMID 28536376 DOI: 10.3390/biomedicines4020009  0.184
2000 Chinnasamy N, Chinnasamy D, Toso JF, Lapointe R, Candotti F, Morgan RA, Hwu P. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors Human Gene Therapy. 11: 1901-1909. PMID 10986562 DOI: 10.1089/10430340050129512  0.183
1993 Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of Virology. 67: 277-87. PMID 8416373 DOI: 10.1128/Jvi.67.1.277-287.1993  0.183
2012 Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G. Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 246-9. PMID 22297819 DOI: 10.1038/Mt.2011.288  0.182
2010 Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood. 116: 4099-102. PMID 20668228 DOI: 10.1182/blood-2010-04-281931  0.182
2001 Lewis BC, Chinnasamy N, Morgan RA, Varmus HE. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. Journal of Virology. 75: 9339-44. PMID 11533197 DOI: 10.1128/Jvi.75.19.9339-9344.2001  0.182
2018 Dakir EH, Pickard A, Srivastava K, McCrudden CM, Gross SR, Lloyd S, Zhang SD, Margariti A, Morgan R, Rudland PS, El-Tanani M. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget. 9: 34889-34910. PMID 30405882 DOI: 10.18632/Oncotarget.26175  0.182
2014 Abate-Daga D, Rosenberg SA, Morgan RA. Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies. Oncoimmunology. 3: e29194. PMID 25083334 DOI: 10.4161/onci.29194  0.181
2015 Platais C, Hakami F, Darda L, Lambert DW, Morgan R, Hunter KD. The role of HOX genes in head and neck squamous cell carcinoma. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. PMID 26661059 DOI: 10.1111/jop.12388  0.181
2009 Jones S, Peng PD, Yang S, Hsu C, Cohen CJ, Zhao Y, Abad J, Zheng Z, Rosenberg SA, Morgan RA. Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Human Gene Therapy. 20: 630-40. PMID 19265475 DOI: 10.1089/hum.2008.048  0.181
2007 Zhao Y, Bennett AD, Zheng Z, Wang QJ, Robbins PF, Yu LY, Li Y, Molloy PE, Dunn SM, Jakobsen BK, Rosenberg SA, Morgan RA. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. Journal of Immunology (Baltimore, Md. : 1950). 179: 5845-54. PMID 17947658 DOI: 10.4049/jimmunol.179.9.5845  0.181
2006 Jones S, Hsu C, Morgan R, Rosenberg S. 767. Genetic Engineering of an Immortal Human CD8+ T Cell Line Molecular Therapy. 13: S297. DOI: 10.1016/j.ymthe.2006.08.852  0.18
2015 Perkins MR, Grande S, Hamel A, Horton HM, Garrett TE, Miller SM, Latimer HJ, Horvath CJ, Kuczewski M, Friedman KM, Morgan RA. Manufacturing an Enhanced CAR T Cell Product By Inhibition of the PI3K/Akt Pathway During T Cell Expansion Results in Improved In Vivo Efficacy of Anti-BCMA CAR T Cells Blood. 126: 1893-1893. DOI: 10.1182/blood.v126.23.1893.1893  0.18
2003 Morgan RA, Dudley ME, Yu YY, Zheng Z, Robbins PF, Theoret MR, Wunderlich JR, Hughes MS, Restifo NP, Rosenberg SA. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. Journal of Immunology (Baltimore, Md. : 1950). 171: 3287-95. PMID 12960359 DOI: 10.4049/Jimmunol.171.6.3287  0.18
1997 Lozier JN, Morgan RA. Gut epithelial cells as targets for gene therapy of hemophilia Human Gene Therapy. 8: 1481-1490. PMID 9287148 DOI: 10.1089/HUM.1997.8.12-1481  0.18
2006 Lotem M, Zhao Y, Riley J, Hwu P, Morgan RA, Rosenberg SA, Parkhurst MR. Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 616-27. PMID 17063124 DOI: 10.1097/01.cji.0000211312.36363.56  0.18
2007 Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha HS. Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Cancer Research. 67: 5806-13. PMID 17575148 DOI: 10.1158/0008-5472.CAN-06-4231  0.179
2006 Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Research. 66: 8878-86. PMID 16951205 DOI: 10.1158/0008-5472.CAN-06-1450  0.179
2019 Leung WH, Gay J, Martin U, Garrett TE, Horton HM, Certo MT, Blazar BR, Morgan RA, Gregory PD, Jarjour J, Astrakhan A. Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization. Jci Insight. 5. PMID 31039141 DOI: 10.1172/Jci.Insight.124430  0.178
2011 Rao M, Chinnasamy N, Hong JA, Zhang Y, Zhang M, Xi S, Liu F, Marquez VE, Morgan RA, Schrump DS. Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. Cancer Research. 71: 4192-204. PMID 21546573 DOI: 10.1158/0008-5472.CAN-10-2442  0.178
2011 Kelly ZL, Michael A, Butler-Manuel S, Pandha HS, Morgan RG. HOX genes in ovarian cancer. Journal of Ovarian Research. 4: 16. PMID 21906307 DOI: 10.1186/1757-2215-4-16  0.177
2009 Wargo JA, Robbins PF, Li Y, Zhao Y, El-Gamil M, Caragacianu D, Zheng Z, Hong JA, Downey S, Schrump DS, Rosenberg SA, Morgan RA. Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunology, Immunotherapy : Cii. 58: 383-94. PMID 18677478 DOI: 10.1007/s00262-008-0562-x  0.177
1995 Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, ... ... Morgan RA, et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (New York, N.Y.). 270: 475-80. PMID 7570001 DOI: 10.1126/Science.270.5235.475  0.177
2014 Feldman SA, Xu H, Black MA, Park TS, Robbins PF, Kochenderfer JN, Morgan RA, Rosenberg SA. Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectors. Human Gene Therapy Methods. 25: 253-60. PMID 25072603 DOI: 10.1089/hgtb.2014.071  0.174
2011 Yang S, Gattinoni L, Luca G, Liu F, Ji Y, Yu Z, Restifo NP, Rosenberg SA, Morgan RA. In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells. Cancer Immunology, Immunotherapy : Cii. 60: 739-49. PMID 21305379 DOI: 10.1007/S00262-011-0977-7  0.174
2003 Lizée G, Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA, Topalian SL. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Human Gene Therapy. 14: 497-507. PMID 12718761 DOI: 10.1089/104303403764539387  0.174
2008 Kochenderfer J, Feldman S, Zhao Y, Xu H, Black M, Morgan R, Dudley M, Wilson W, Rosenberg S. Construction and Pre-Clinical Evaluation of An Anti-CD19 Chimeric Antigen Receptor Blood. 112: 4623-4623. DOI: 10.1182/BLOOD.V112.11.4623.4623  0.174
2012 Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael A, Pandha HS. Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Research and Treatment. 136: 389-98. PMID 23053648 DOI: 10.1007/s10549-012-2259-2  0.173
2005 Morgan R, Pettengell R, Sohal J. The double life of HOXB4. Febs Letters. 578: 1-4. PMID 15581606 DOI: 10.1016/j.febslet.2004.11.002  0.173
2003 Rossi GR, Mautino MR, Morgan RA. High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytes. Human Gene Therapy. 14: 385-91. PMID 12659679 DOI: 10.1089/104303403321208989  0.173
2019 Idaikkadar P, Morgan R, Michael A. HOX Genes in High Grade Ovarian Cancer. Cancers. 11. PMID 31382546 DOI: 10.3390/cancers11081107  0.173
1992 Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Research. 20: 1293-9. PMID 1313966 DOI: 10.1093/Nar/20.6.1293  0.172
2011 Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA, Restifo NP. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. The Journal of Clinical Investigation. 121: 4746-57. PMID 22056381 DOI: 10.1172/Jci58814  0.172
2004 Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 892-902. PMID 15509507 DOI: 10.1016/J.Ymthe.2004.08.006  0.172
2008 Morgan R, Whiting K. Differential expression of HOX genes upon activation of leukocyte sub-populations. International Journal of Hematology. 87: 246-9. PMID 18317880 DOI: 10.1007/s12185-008-0057-8  0.171
1997 Jensen TG, Sullivan DM, Morgan RA, Taichman LB, Nussenblatt RB, Blaese RM, Csaky KG. Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patients. Human Gene Therapy. 8: 2125-32. PMID 9414260 DOI: 10.1089/Hum.1997.8.17-2125  0.171
2012 Lagisetty KH, Morgan RA. Cancer therapy with genetically-modified T cells for the treatment of melanoma. The Journal of Gene Medicine. 14: 400-4. PMID 22610729 DOI: 10.1002/jgm.2636  0.17
1999 Wahlfors JJ, Morgan RA. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Human Gene Therapy. 10: 1197-206. PMID 10340551 DOI: 10.1089/10430349950018184  0.17
2008 Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nature Reviews. Cancer. 8: 299-308. PMID 18354418 DOI: 10.1038/Nrc2355  0.17
1993 Cornetta K, Nguyen N, Morgan RA, Muenchau DD, Hartley JW, Blaese RM, Anderson WF. Infection of human cells with murine amphotropic replication-competent retroviruses. Human Gene Therapy. 4: 579-88. PMID 8280796 DOI: 10.1089/Hum.1993.4.5-579  0.169
2018 Raje NS, Berdeja JG, Lin Y, Munshi NC, Siegel DSD, Liedtke M, Jagannath S, Madduri D, Rosenblatt J, Maus MV, Turka A, Lam LP, Morgan RA, Quigley T, Massaro M, et al. bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study. Journal of Clinical Oncology. 36: 8007-8007. DOI: 10.1200/Jco.2018.36.15_Suppl.8007  0.169
2012 Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, ... Morgan RA, et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood. 119: 2709-20. PMID 22160384 DOI: 10.1182/blood-2011-10-384388  0.169
2011 Bonini C, Brenner MK, Heslop HE, Morgan RA. Genetic modification of T cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: S15-20. PMID 21195304 DOI: 10.1016/j.bbmt.2010.09.019  0.169
2018 Platais C, Radhakrishnan R, Ebensberger SN, Morgan R, Lambert DW, Hunter KD. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes. Bmc Cancer. 18: 723. PMID 29980182 DOI: 10.1186/s12885-018-4622-0  0.169
2017 Berdeja JG, Lin Y, Raje NS, Siegel DSD, Munshi NC, Liedtke M, Jagannath S, Maus MV, Turka A, Lam LP, Hege K, Morgan R, Quigley MT, Kochenderfer J. First-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: Updated results. Journal of Clinical Oncology. 35: 3010-3010. DOI: 10.1200/Jco.2017.35.15_Suppl.3010  0.168
2019 Primon M, Hunter KD, Pandha HS, Morgan R. Kinase Regulation of HOX Transcription Factors. Cancers. 11. PMID 30974835 DOI: 10.3390/cancers11040508  0.168
2012 Adair RA, Roulstone V, Scott KJ, Morgan R, Nuovo GJ, Fuller M, Beirne D, West EJ, Jennings VA, Rose A, Kyula J, Fraser S, Dave R, Anthoney DA, Merrick A, et al. Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Science Translational Medicine. 4: 138ra77. PMID 22700953 DOI: 10.1126/Scitranslmed.3003578  0.168
1997 Nelson DM, Metzger ME, Donahue RE, Morgan RA. In vivo retrovirus-mediated gene transfer into multiple hematopoietic lineages in rabbits without preconditioning. Human Gene Therapy. 8: 747-54. PMID 9113514 DOI: 10.1089/hum.1997.8.6-747  0.167
2011 Yang S, Liu F, Wang QJ, Rosenberg SA, Morgan RA. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. Plos One. 6: e22560. PMID 21829468 DOI: 10.1371/journal.pone.0022560  0.167
2010 Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G, Restifo NP. Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Research. 70: 6725-34. PMID 20647327 DOI: 10.1158/0008-5472.Can-10-0735  0.167
2009 Ismail M, Bokaee S, Morgan R, Davies J, Harrington KJ, Pandha H. Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. British Journal of Cancer. 100: 1889-95. PMID 19513079 DOI: 10.1038/sj.bjc.6605093  0.166
2014 Sampson JH, Choi BD, Sanchez-Perez L, Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap EA, Norberg PK, Herndon JE, Kuan CT, Morgan RA, Rosenberg SA, Johnson LA. EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 972-84. PMID 24352643 DOI: 10.1158/1078-0432.CCR-13-0709  0.166
2009 Zhao Y, Wang QJ, Yang S, Kochenderfer JN, Zheng Z, Zhong X, Sadelain M, Eshhar Z, Rosenberg SA, Morgan RA. A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. Journal of Immunology (Baltimore, Md. : 1950). 183: 5563-74. PMID 19843940 DOI: 10.4049/Jimmunol.0900447  0.166
2017 Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS. Targeting HOX/PBX dimers in cancer. Oncotarget. PMID 28423659 DOI: 10.18632/oncotarget.15971  0.165
2013 Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA, Restifo NP. Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1369-77. PMID 23568260 DOI: 10.1038/Mt.2013.58  0.165
1994 Morgan RA, Baler-Bitterlich G, Ragheb JA, Wong-Staal F, Gallo RC, Anderson WF. Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1. Aids Research and Human Retroviruses. 10: 1507-15. PMID 7888205 DOI: 10.1089/Aid.1994.10.1507  0.165
2014 Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A, Pandha HS. Targeting HOX transcription factors in prostate cancer. Bmc Urology. 14: 17. PMID 24499138 DOI: 10.1186/1471-2490-14-17  0.164
2008 Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. Journal of Immunology (Baltimore, Md. : 1950). 180: 6116-31. PMID 18424733 DOI: 10.4049/Jimmunol.180.9.6116  0.164
2019 Raje N, Berdeja J, Lin Y, Siegel D, Jagannath S, Madduri D, Liedtke M, Rosenblatt J, Maus MV, Turka A, Lam LP, Morgan RA, Friedman K, Massaro M, Wang J, et al. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma. The New England Journal of Medicine. 380: 1726-1737. PMID 31042825 DOI: 10.1056/Nejmoa1817226  0.164
2014 Wen W, Liang W, Wu J, Kowolik CM, Buettner R, Scuto A, Hsieh MY, Hong H, Brown CE, Forman SJ, Horne D, Morgan R, Wakabayashi M, Dellinger TH, Han ES, et al. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer. Molecular Cancer Therapeutics. 13: 3037-48. PMID 25319391 DOI: 10.1158/1535-7163.Mct-14-0077  0.163
2000 Caplen NJ, Fleenor J, Fire A, Morgan RA. dsRNA-mediated gene silencing in cultured Drosophila cells: A tissue culture model for the analysis of RNA interference Gene. 252: 95-105. PMID 10903441 DOI: 10.1016/S0378-1119(00)00224-9  0.162
2011 Gray S, Pandha HS, Michael A, Middleton G, Morgan R. HOX genes in pancreatic development and cancer. Jop : Journal of the Pancreas. 12: 216-9. PMID 21546695  0.162
2000 Wahlfors JJ, Zullo SA, Loimas S, Nelson DM, Morgan RA. Evaluation of recombinant alphaviruses as vectors in gene therapy. Gene Therapy. 7: 472-80. PMID 10757020 DOI: 10.1038/sj.gt.3301122  0.162
2022 Padam KSR, Morgan R, Hunter K, Chakrabarty S, Kumar NAN, Radhakrishnan R. Identification of HOX signatures contributing to oral cancer phenotype. Scientific Reports. 12: 10123. PMID 35710803 DOI: 10.1038/s41598-022-14412-6  0.162
2012 Twigger K, Roulstone V, Kyula J, Karapanagiotou EM, Syrigos KN, Morgan R, White C, Bhide S, Nuovo G, Coffey M, Thompson B, Jebar A, Errington F, Melcher AA, Vile RG, et al. Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. Bmc Cancer. 12: 368. PMID 22920673 DOI: 10.1186/1471-2407-12-368  0.162
2016 Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, Idrisoglu S, Manning S, ... ... Morgan RA, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. PMID 26909576 DOI: 10.1038/Nature16965  0.162
2014 Morgan RA, Kakarla S. Genetic modification of T cells. Cancer Journal (Sudbury, Mass.). 20: 145-50. PMID 24667961 DOI: 10.1097/PPO.0000000000000033  0.162
1997 Chen L, Perlick H, Morgan RA. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX. Human Gene Therapy. 8: 125-35. PMID 9017417 DOI: 10.1089/HUM.1997.8.2-125  0.161
2010 Yang S, Dudley ME, Rosenberg SA, Morgan RA. A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 648-58. PMID 20551831 DOI: 10.1097/CJI.0b013e3181e311cb  0.161
2012 Zhang L, Feldman SA, Zheng Z, Chinnasamy N, Xu H, Nahvi AV, Dudley ME, Rosenberg SA, Morgan RA. Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35: 430-9. PMID 22576348 DOI: 10.1097/CJI.0b013e31825898e8  0.161
1990 Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, Anderson WF. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. Aids Research and Human Retroviruses. 6: 183-91. PMID 2328156 DOI: 10.1089/Aid.1990.6.183  0.161
2013 Chinnasamy D, Tran E, Yu Z, Morgan RA, Restifo NP, Rosenberg SA. Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice. Cancer Research. 73: 3371-80. PMID 23633494 DOI: 10.1158/0008-5472.Can-12-3913  0.161
2010 Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS. Targeting HOX and PBX transcription factors in ovarian cancer. Bmc Cancer. 10: 89. PMID 20219106 DOI: 10.1186/1471-2407-10-89  0.16
2013 Zhang Y, Morgan R, Podack ER, Rosenblatt J. B cell regulation of anti-tumor immune response. Immunologic Research. 57: 115-24. PMID 24293009 DOI: 10.1007/S12026-013-8472-1  0.16
1995 Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 92: 7739-43. PMID 7644487 DOI: 10.1073/Pnas.92.17.7739  0.16
2000 Chinnasamy D, Chinnasamy N, Enriquez MJ, Otsu M, Morgan RA, Candotti F. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins Blood. 96: 1309-1316. DOI: 10.1182/BLOOD.V96.4.1309  0.159
2000 Chinnasamy D, Chinnasamy N, Enriquez MJ, Otsu M, Morgan RA, Candotti F. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins Blood. 96: 1309-1316. DOI: 10.1182/blood.v96.4.1309.h8001309_1309_1316  0.159
2013 McGrath SE, Michael A, Pandha H, Morgan R. Engrailed homeobox transcription factors as potential markers and targets in cancer. Febs Letters. 587: 549-54. PMID 23395604 DOI: 10.1016/j.febslet.2013.01.054  0.158
2019 Elamin AA, Klunkelfuß S, Kämpfer S, Oehlmann W, Stehr M, Smith C, Simpson GR, Morgan R, Pandha H, Singh M. A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection. Frontiers in Oncology. 9: 1484. PMID 31993369 DOI: 10.3389/fonc.2019.01484  0.158
2015 El-Sherbiny YM, Holmes TD, Wetherill LF, Black EV, Wilson EB, Phillips SL, Scott GB, Adair RA, Dave R, Scott KJ, Morgan RS, Coffey M, Toogood GJ, Melcher AA, Cook GP. Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo. Clinical and Experimental Immunology. 180: 98-107. PMID 25469725 DOI: 10.1111/cei.12562  0.158
2014 Zabkiewicz J, Pearn L, Hills RK, Morgan RG, Tonks A, Burnett AK, Darley RL. The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts. Haematologica. 99: 858-64. PMID 24334295 DOI: 10.3324/haematol.2013.096487  0.158
2013 Beard RE, Abate-Daga D, Rosati SF, Zheng Z, Wunderlich JR, Rosenberg SA, Morgan RA. Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4941-50. PMID 24021875 DOI: 10.1158/1078-0432.CCR-13-1253  0.157
2013 Alharbi RA, Pettengell R, Pandha HS, Morgan R. The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia. 27: 1000-8. PMID 23212154 DOI: 10.1038/leu.2012.356  0.155
2009 Ismail M, Morgan R, Harrington K, Davies J, Pandha H. Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. Cryobiology. 59: 207-13. PMID 19646431 DOI: 10.1016/j.cryobiol.2009.07.008  0.154
2015 Justice JF, Morgan RW, Beemon KL. Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas. Mbio. 6. PMID 26670384 DOI: 10.1128/mBio.01863-15  0.154
1999 Morgan RA, Blaese RM. Gene therapy: lessons learnt from the past decade. Interview by Clare Thompson. Bmj (Clinical Research Ed.). 319: 1310. PMID 10559061 DOI: 10.1136/Bmj.319.7220.1310  0.153
2010 Chinnasamy N, Morgan RA. Recent progress and future directions using engineered T cells for the treatment of cancer Gene Therapy and Regulation. 5: 67-80. DOI: 10.1142/S1568558610000161  0.153
1990 Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF. Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction New England Journal of Medicine. 323: 570-578. PMID 2381442 DOI: 10.1056/Nejm199008303230904  0.153
2005 Morgan R. Hox genes: a continuation of embryonic patterning? Trends in Genetics : Tig. 22: 67-9. PMID 16325300 DOI: 10.1016/j.tig.2005.11.004  0.153
2022 Shenoy US, Morgan R, Hunter K, Kabekkodu SP, Radhakrishnan R. Integrated computational analysis reveals HOX genes cluster as oncogenic drivers in head and neck squamous cell carcinoma. Scientific Reports. 12: 7952. PMID 35562533 DOI: 10.1038/s41598-022-11590-1  0.153
2015 Ladd A, Lilley G, Li M, Cossette D, Hopkins GW, Maier D, Paglia M, Morgan RA. A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P117  0.153
2011 Kochenderfer J, Dudley M, Maric I, Feldman S, Salit R, Hardy N, Layton P, Blacklock-Schuver B, Wilder J, Devillier L, Gress R, Morgan R, Rosenberg S, Bishop M. Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 17: S158. DOI: 10.1016/J.BBMT.2010.12.025  0.152
2010 Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. Journal of Immunology (Baltimore, Md. : 1950). 184: 5988-98. PMID 20427771 DOI: 10.4049/Jimmunol.1000189  0.152
2005 Morgan R, Begum R, Theti D, Chansa M, Pettengell R, Sohal J. HOXA9 expression increases with age in human haemopoietic cells. Leukemia Research. 29: 1221-2. PMID 16111538 DOI: 10.1016/j.leukres.2005.03.007  0.152
2015 Beane JD, Lee G, Zheng Z, Gandhi N, Abate-Daga D, Bharathan M, Black M, Mendel M, Yu Z, Kassim SH, Chandran S, Giedlin MA, Ando D, Rebar E, Reik A, ... ... Morgan RA, et al. 77. Clinical Scale Zinc Finger Nuclease (ZFN)-Driven Gene-Editing of PD-1 in Tumor Infiltrating Lymphocytes (TIL) for the Potential Treatment of Metastatic Melanoma Molecular Therapy. 23: S33-S34. DOI: 10.1016/S1525-0016(16)33682-6  0.151
2015 Morgan R, Simpson G, Gray S, Gillett C, Tabi Z, Spicer J, Harrington KJ, Pandha HS. HOX transcription factors are potential targets and markers in malignant mesothelioma. Bmc Cancer. 16: 85. PMID 26867567 DOI: 10.1186/S12885-016-2106-7  0.15
2010 Ismail M, Morgan R, Harrington K, Davies J, Pandha H. Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model. Cryobiology. 61: 268-74. PMID 20863822 DOI: 10.1016/j.cryobiol.2010.09.004  0.15
2002 Mautino MR, Morgan RA. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA. Human Gene Therapy. 13: 1027-37. PMID 12067436 DOI: 10.1089/104303402753812430  0.15
2002 Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA. Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Human Molecular Genetics. 11: 175-84. PMID 11809726 DOI: 10.1093/Hmg/11.2.175  0.15
2012 Frazier DP, Kendig RD, Kai F, Maglic D, Sugiyama T, Morgan RL, Fry EA, Lagedrost SJ, Sui G, Inoue K. Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function. Cancer Research. 72: 1740-50. PMID 22331460 DOI: 10.1158/0008-5472.Can-11-2410  0.15
2012 Zheng Z, Chinnasamy N, Morgan RA. Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry. Journal of Translational Medicine. 10: 29. PMID 22330761 DOI: 10.1186/1479-5876-10-29  0.15
2014 El-Jawhari JJ, El-Sherbiny YM, Scott GB, Morgan RS, Prestwich R, Bowles PA, Blair GE, Tanaka T, Rabbitts TH, Meade JL, Cook GP. Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes. Molecular Immunology. 58: 160-8. PMID 24365750 DOI: 10.1016/j.molimm.2013.11.020  0.148
2020 Morgan RA, Ma F, Unti MJ, Brown D, Ayoub PG, Tam C, Lathrop L, Aleshe B, Kurita R, Nakamura Y, Senadheera S, Wong RL, Hollis RP, Pellegrini M, Kohn DB. Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences. Molecular Therapy. Methods & Clinical Development. 17: 999-1013. PMID 32426415 DOI: 10.1016/J.Omtm.2020.04.006  0.148
2011 Zhang L, Kerkar SP, Yu Z, Zheng Z, Yang S, Restifo NP, Rosenberg SA, Morgan RA. Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 751-9. PMID 21285960 DOI: 10.1038/Mt.2010.313  0.148
2010 Frankel TL, Burns W, Riley J, Morgan RA, Davis JL, Hanada K, Quezado M, Rosenberg SA, Royal RE. Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. Cancer Immunology, Immunotherapy : Cii. 59: 1757-69. PMID 20734041 DOI: 10.1007/s00262-010-0897-y  0.148
1990 Culver KW, Morgan RA, Osborne WRA, Lee RT, Lenschow D, Able C, Cornetta K, Anderson WF, Blaese RM. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys Human Gene Therapy. 1: 399-410. PMID 1964096 DOI: 10.1089/Hum.1990.1.4-399  0.148
2002 Mautino MR, Morgan RA. Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes. Aids Patient Care and Stds. 16: 11-26. PMID 11839215 DOI: 10.1089/108729102753429361  0.148
2012 Seaman BJ, Guardiani EA, Brewer CC, Zalewski CK, King KA, Rudy S, Van Waes C, Morgan RA, Dudley ME, Yang JC, Rosenberg SA, Kim HJ. Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 147: 744-9. PMID 22597578 DOI: 10.1177/0194599812448356  0.147
2009 Frankel T, Rosenberg S, Morgan R. 185. Cloning and Modification of a T-Cell Receptor Gene Targeting Tyrosinase Confers Peptide and HLA Specific Reactivity to Transduced Peripheral Blood Lymphocytes Journal of Surgical Research. 151: 256-257. DOI: 10.1016/J.JSS.2008.11.224  0.146
2000 Mautino MR, Ramsey WJ, Reiser J, Morgan RA. Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev. Human Gene Therapy. 11: 895-908. PMID 10779166 DOI: 10.1089/10430340050015509  0.145
2010 Bialer G, Horovitz-Fried M, Ya'acobi S, Morgan RA, Cohen CJ. Selected murine residues endow human TCR with enhanced tumor recognition. Journal of Immunology (Baltimore, Md. : 1950). 184: 6232-41. PMID 20427762 DOI: 10.4049/jimmunol.0902047  0.145
2012 Tagawa T, Morgan R, Yen Y, Mortimer J. Ovarian cancer: opportunity for targeted therapy. Journal of Oncology. 2012: 682480. PMID 22235203 DOI: 10.1155/2012/682480  0.145
2017 Morgan RA, Gray D, Lomova A, Kohn DB. Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned. Cell Stem Cell. 21: 574-590. PMID 29100011 DOI: 10.1016/J.Stem.2017.10.010  0.145
2012 Haso W, Lee D, Morgan R, Pastan I, Mackall C, Orentas RJ. Abstract 3504: Generation and optimization of a chimeric antigen receptor against human CD22: A new immunotherapeutic agent for adoptive immunotherapy Cancer Research. 72: 3504-3504. DOI: 10.1158/1538-7445.Am2012-3504  0.144
2011 Heinemann L, Simpson GR, Boxall A, Kottke T, Relph KL, Vile R, Melcher A, Prestwich R, Harrington KJ, Morgan R, Pandha HS. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. Bmc Cancer. 11: 221. PMID 21645351 DOI: 10.1186/1471-2407-11-221  0.144
2022 Wong RL, Sackey S, Brown D, Senadheera S, Masiuk K, Quintos JP, Colindres N, Riggan L, Morgan RA, Malech HL, Hollis RP, Kohn DB. Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease Recapitulates Endogenous CYBB Regulation and Expression. Blood. PMID 36332160 DOI: 10.1182/blood.2022016074  0.144
1998 Wahlfors JJ, Xanthopoulos KG, Morgan RA. Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Human Gene Therapy. 8: 2031-41. PMID 9414252 DOI: 10.1089/HUM.1997.8.17-2031  0.144
2016 Zhang Y, Morgan R, Chen C, Cai Y, Clark E, Khan WN, Shin SU, Cho HM, Bayati AA, Pimentel A, Rosenblatt JD. Mammary Tumor Educated B cells Acquire LAP/TGF- and PD-L1 expression and Suppress Anti-Tumor Immune Response. International Immunology. PMID 26895637 DOI: 10.1093/intimm/dxw007  0.144
2011 Yang S, Gattinoni L, Liu F, Ji Y, Yu Z, Restifo NP, Rosenberg SA, Morgan RA. Erratum to: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells Cancer Immunology, Immunotherapy. 60: 751-751. DOI: 10.1007/S00262-011-0994-6  0.144
2015 Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, ... Morgan RA, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 518: 495-501. PMID 25719666 DOI: 10.1038/Nature14169  0.143
2010 Kushner EJ, Weil BR, MacEneaney OJ, Morgan RG, Mestek ML, Van Guilder GP, Diehl KJ, Stauffer BL, DeSouza CA. Human aging and CD31+ T-cell number, migration, apoptotic susceptibility, and telomere length. Journal of Applied Physiology (Bethesda, Md. : 1985). 109: 1756-61. PMID 20864561 DOI: 10.1152/Japplphysiol.00601.2010  0.143
2012 Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, ... Morgan RA, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 491: 399-405. PMID 23103869 DOI: 10.1038/Nature11547  0.143
2005 Moayer M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. Erratum to "Sustained Phenotypic Correction of Hemophilia A Mice Following Oncoretroviral-Mediated Expression of a Bioengineered Human Factor VIII Gene in Long-Term Hematopoietic Repopulating Cells". Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 579-580. PMID 28178461 DOI: 10.1016/j.ymthe.2004.11.005  0.142
2015 Garrett TE, Chekmasova AA, Evans JW, Seidel SL, Horton HM, Latimer HJ, Griecci JA, Horvath CJ, Ryu BY, Friedman KM, Morgan RA. A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P124  0.142
1999 Ragheb JA, Couture L, Mullen C, Ridgway A, Morgan RA. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev. Human Gene Therapy. 10: 103-12. PMID 10022535 DOI: 10.1089/10430349950019237  0.142
2022 Luyten YA, Hausman DE, Young JC, Doyle LA, Higashi KM, Ubilla-Rodriguez NC, Lambert AR, Arroyo CS, Forsberg KJ, Morgan RD, Stoddard BL, Kaiser BK. Identification and characterization of the WYL BrxR protein and its gene as separable regulatory elements of a BREX phage restriction system. Nucleic Acids Research. PMID 35511079 DOI: 10.1093/nar/gkac311  0.141
2013 Morgan R, Bryan RT, Javed S, Launchbury F, Zeegers MP, Cheng KK, James ND, Wallace DM, Hurst CD, Ward DG, Knowles MA, Pandha H. Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer (Oxford, England : 1990). 49: 2214-22. PMID 23434148 DOI: 10.1016/j.ejca.2013.01.019  0.141
2011 Frankel TL, Zhang L, Burns WR, Zheng Z, Morgan RA. The position of the AUG start codon in MFG-based γ-retroviral vectors has a dramatic effect on translation-dependent protein expression. The Journal of Gene Medicine. 13: 478-86. PMID 21796743 DOI: 10.1002/jgm.1599  0.139
1998 Evans GL, Morgan RA. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proceedings of the National Academy of Sciences of the United States of America. 95: 5734-9. PMID 9576953 DOI: 10.1073/PNAS.95.10.5734  0.139
2015 Morgan RG, Molnár E, Jones RF, Collard TJ, Lane JD, Greenhough A, Paraskeva C, Williams AC. Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells. British Journal of Cancer. 112: 714-9. PMID 25611300 DOI: 10.1038/Bjc.2015.4  0.139
2014 Bot A, Chiriva-Internati M, Cornforth A, Czerniecki BJ, Ferrone S, Geles K, Greenberg PD, Hurt E, Koya RC, Manjili MH, Matsui W, Morgan RA, Palena CM, Powell Jr DJ, Restifo NP, et al. Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-6  0.139
2012 Chinnasamy D, Yu Z, Kerkar SP, Zhang L, Morgan RA, Restifo NP, Rosenberg SA. Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1672-83. PMID 22291136 DOI: 10.1158/1078-0432.Ccr-11-3050  0.138
2013 Zhang L, Yu Z, Muranski P, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA. Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy. Gene Therapy. 20: 575-80. PMID 22972494 DOI: 10.1038/Gt.2012.75  0.138
2013 Morgan RA. Adoptive T-cell Therapy: Engineering T-cell Receptors Cancer Immunotherapy: Immune Suppression and Tumor Growth: Second Edition. 261-272. DOI: 10.1016/B978-0-12-394296-8.00017-8  0.138
1997 Bunnell BA, Metzger M, Byrne E, Morgan RA, Donahue RE. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retrovital vector Blood. 89: 1987-1995. PMID 9058720 DOI: 10.1182/Blood.V89.6.1987  0.138
2013 Hsu C, Abad J, Morgan R. A Bicistronic Retroviral Vector Expressing IL-15 and Herpes Simplex Virus Thymidine Kinase for the Transduction of Human T Lymphocytes for Adoptive Cell Transfer Therapies Journal of Surgical Research. 179: 341. DOI: 10.1016/J.JSS.2012.10.798  0.137
2021 Zhang L, Zuris JA, Viswanathan R, Edelstein JN, Turk R, Thommandru B, Rube HT, Glenn SE, Collingwood MA, Bode NM, Beaudoin SF, Lele S, Scott SN, Wasko KM, Sexton S, ... ... Morgan RA, et al. Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines. Nature Communications. 12: 4500. PMID 34282150 DOI: 10.1038/s41467-021-24770-w  0.137
1998 Davis BR, Saitta FP, Bauer G, Bunnell BA, Morgan RA, Schwartz DH. Targeted transduction of CD34+ cells by transdominant negative Rev-expressing retrovirus yields partial anti-HIV protection of progeny macrophages. Human Gene Therapy. 9: 1197-207. PMID 9625259 DOI: 10.1089/Hum.1998.9.8-1197  0.137
1992 Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. Journal of Virology. 66: 7159-67. PMID 1279199 DOI: 10.1128/Jvi.66.12.7159-7167.1992  0.136
2012 Somlo G, Martel CL, Lau SK, Frankel P, Ruel C, Gu L, Hurria A, Chung C, Luu T, Morgan R, Leong L, Koczywas M, McNamara M, Russell CA, Kane SE. A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer. Breast Cancer Research and Treatment. 131: 899-906. PMID 22042372 DOI: 10.1007/s10549-011-1850-2  0.136
2011 Orentas RJ, Haso W, Morgan RA, Pastan I, Mackall CL. Generation and Optimization of a Chimeric Antigen Receptor Against CD22: A New Immunotherapeutic Agent for Treating B Lineage Leukemia and Lymphoma Blood. 118: 4313-4313. DOI: 10.1182/Blood.V118.21.4313.4313  0.135
1996 Ragheb JA, Bressler P, Daucher M, Chiang L, Chuah MK, VandenDriessche T, Morgan RA. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics. Aids Research and Human Retroviruses. 11: 1343-53. PMID 8573391 DOI: 10.1089/AID.1995.11.1343  0.134
1997 Onodera M, Yachie A, Nelson DM, Welchlin H, Morgan RA, Blaese RM. A simple and reliable method for screening retroviral producer clones without selectable markers. Human Gene Therapy. 8: 1189-94. PMID 9215736 DOI: 10.1089/Hum.1997.8.10-1189  0.134
1999 Bunnell BA, Kluge KA, Lee-Lin SQ, Byrne ER, Orlic D, Metzger ME, Agricola BA, Wersto RP, Bodine DM, Morgan RA, Donahue RE. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells. Gene Therapy. 6: 48-56. PMID 10341875 DOI: 10.1038/sj.gt.3300808  0.134
2013 Yang S, Ji Y, Gattinoni L, Zhang L, Yu Z, Restifo NP, Rosenberg SA, Morgan RA. Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunology, Immunotherapy : Cii. 62: 727-36. PMID 23207483 DOI: 10.1007/S00262-012-1378-2  0.133
2002 Caplen NJ, Zheng Z, Falgout B, Morgan RA. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 243-51. PMID 12161191 DOI: 10.1006/MTHE.2002.0652  0.133
2002 Morsi El-Kadi AS, in der Reiden P, Durston A, Morgan R. The small GTPase Rap1 is an immediate downstream target for Hoxb4 transcriptional regulation. Mechanisms of Development. 113: 131-9. PMID 11960701 DOI: 10.1016/s0925-4773(02)00047-3  0.132
2015 Beane JD, Lee G, Zheng Z, Mendel M, Abate-Daga D, Bharathan M, Black M, Gandhi N, Yu Z, Chandran S, Giedlin M, Ando D, Miller J, Paschon D, Guschin D, ... ... Morgan RA, et al. Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 25939491 DOI: 10.1038/Mt.2015.71  0.132
2012 VanderWalde A, Ye W, Frankel P, Asuncion D, Leong L, Luu T, Morgan R, Twardowski P, Koczywas M, Pezner R, Paz IB, Margolin K, Wong J, Doroshow JH, Forman S, et al. Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1273-80. PMID 22306735 DOI: 10.1016/j.bbmt.2012.01.021  0.132
2012 Kummar S, Ji J, Morgan R, Lenz HJ, Puhalla SL, Belani CP, Gandara DR, Allen D, Kiesel B, Beumer JH, Newman EM, Rubinstein L, Chen A, Zhang Y, Wang L, et al. A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1726-34. PMID 22307137 DOI: 10.1158/1078-0432.Ccr-11-2821  0.132
2005 Morgan RA, Walker R, Carter CS, Natarajan V, Tavel JA, Bechtel C, Herpin B, Muul L, Zheng Z, Jagannatha S, Bunnell BA, Fellowes V, Metcalf JA, Stevens R, Baseler M, et al. Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals. Human Gene Therapy. 16: 1065-74. PMID 16149905 DOI: 10.1089/Hum.2005.16.1065  0.132
2013 Moody P, Burlina F, Martin SR, Morgan RE, Offer J, Smith ME, Molloy JE, Caddick S. Evaluating the use of Apo-neocarzinostatin as a cell penetrating protein. Protein Engineering, Design & Selection : Peds. 26: 277-81. PMID 23322746 DOI: 10.1093/protein/gzs104  0.131
2016 Humphris JL, Patch AM, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, ... ... Morgan RA, et al. Hypermutation In Pancreatic Cancer. Gastroenterology. PMID 27856273 DOI: 10.1053/j.gastro.2016.09.060  0.13
2013 Hsu C, Abad JD, Morgan RA. Characterization of human T lymphocytes engineered to express interleukin-15 and herpes simplex virus-thymidine kinase. The Journal of Surgical Research. 184: 282-9. PMID 23582229 DOI: 10.1016/j.jss.2013.03.054  0.13
1995 Treisman J, Hwu P, Minamoto S, Shafer G, Cowherd R, Morgan R, Rosenberg S. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen Blood. 85: 139-145. DOI: 10.1182/BLOOD.V85.1.139.BLOODJOURNAL851139  0.129
1991 Lothrop CD, al-Lebban ZS, Niemeyer GP, Jones JB, Peterson MG, Smith JR, Baker HJ, Morgan RA, Eglitis MA, Anderson WF. Expression of a foreign gene in cats reconstituted with retroviral vector infected autologous bone marrow. Blood. 78: 237-45. PMID 2070056  0.129
2015 Dowling P, Pollard D, Larkin A, Henry M, Meleady P, Gately K, O'Byrne K, Barr MP, Lynch V, Ballot J, Crown J, Moriarty M, O'Brien E, Morgan R, Clynes M. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Molecular Biosystems. 11: 743-52. PMID 25483567 DOI: 10.1039/C4Mb00384E  0.129
2004 Morgan R, Nalliah A, Morsi El-Kadi AS. FLASH, a component of the FAS-CAPSASE8 apoptotic pathway, is directly regulated by Hoxb4 in the notochord. Developmental Biology. 265: 105-12. PMID 14697356 DOI: 10.1016/j.ydbio.2003.09.030  0.129
2013 Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, et al. Ovarian cancer, version 2.2013. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 1199-209. PMID 24142821 DOI: 10.6004/Jnccn.2013.0142  0.129
2011 Metcalf S, Pandha HS, Morgan R. Antiangiogenic effects of zoledronate on cancer neovasculature. Future Oncology (London, England). 7: 1325-33. PMID 22044205 DOI: 10.2217/fon.11.113  0.128
2016 Friedman K, Horton H, Perkins M, Grande S, Garrett T, Morgan R. 747. Towards the Clinical Application of BCMA CAR T Cells: The Importance of Reduced Tonic Signaling and Methods to Enhance Memory T Cells Molecular Therapy. 24: S295. DOI: 10.1016/S1525-0016(16)33555-9  0.128
2004 Morgan R, El-Kadi AM, Theokli C. Flamingo, a cadherin-type receptor involved in the Drosophila planar polarity pathway, can block signaling via the canonical wnt pathway in Xenopus laevis. The International Journal of Developmental Biology. 47: 245-52. PMID 12755329  0.127
2013 Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ, Hughes MS, Kammula US, Miller AD, Hessman CJ, et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 133-51. PMID 23377668 DOI: 10.1097/Cji.0B013E3182829903  0.127
2003 Kang EM, De Witte M, Malech H, Morgan RA, Carter C, Leitman SF, Childs R, Barrett AJ, Little R, Tisdale JF. Gene therapy-based treatment for HIV-positive patients with malignancies. Journal of Hematotherapy & Stem Cell Research. 11: 809-16. PMID 12427287 DOI: 10.1089/152581602760404612  0.127
2018 McGrath SE, Annels N, Madhuri TK, Tailor A, Butler-Manuel SA, Morgan R, Pandha H, Michael A. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer. Bmc Cancer. 18: 943. PMID 30285763 DOI: 10.1186/s12885-018-4816-5  0.126
2011 Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, Restifo NP, Robbins PF, Rosenberg SA, Morgan RA. A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. Journal of Immunology (Baltimore, Md. : 1950). 186: 685-96. PMID 21149604 DOI: 10.4049/Jimmunol.1001775  0.125
2016 Grau J, Reschke M, Erkes A, Streubel J, Morgan RD, Wilson GG, Koebnik R, Boch J. AnnoTALE: bioinformatics tools for identification, annotation, and nomenclature of TALEs from Xanthomonas genomic sequences. Scientific Reports. 6: 21077. PMID 26876161 DOI: 10.1038/srep21077  0.125
2011 Feldman SA, Goff SL, Xu H, Black MA, Kochenderfer JN, Johnson LA, Yang JC, Wang Q, Parkhurst MR, Cross S, Morgan RA, Cornetta K, Rosenberg SA. Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells. Human Gene Therapy. 22: 107-15. PMID 20662590 DOI: 10.1089/Hum.2010.064  0.124
2015 Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM. NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 1337-46. PMID 26553764 DOI: 10.6004/Jnccn.2015.0163  0.123
2019 Mücke S, Reschke M, Erkes A, Schwietzer CA, Becker S, Streubel J, Morgan RD, Wilson GG, Grau J, Boch J. Transcriptional Reprogramming of Rice Cells by TALEs. Frontiers in Plant Science. 10: 162. PMID 30858855 DOI: 10.3389/fpls.2019.00162  0.123
2015 Zhang L, Morgan RA, Beane JD, Zheng Z, Dudley ME, Kassim SH, Nahvi AV, Ngo LT, Sherry RM, Phan GQ, Hughes MS, Kammula US, Feldman SA, Toomey MA, Kerkar SP, et al. Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2278-88. PMID 25695689 DOI: 10.1158/1078-0432.Ccr-14-2085  0.122
1991 Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral-mediated gene transfer in humans. Human Gene Therapy. 2: 5-14. PMID 1863639 DOI: 10.1089/HUM.1991.2.1-5  0.122
1995 Chuah MK, VandenDriessche T, Chang HK, Ensoli B, Morgan RA. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR. Human Gene Therapy. 5: 1467-75. PMID 7711139 DOI: 10.1089/HUM.1994.5.12-1467  0.122
2013 Sommariva M, Cheung F, Chen J, Shi R, Zhang L, Morgan R, Bedognetti D, De Giorgi V, Ascierto ML, Rosenberg SA, Marincola FM, Wang E. Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P63  0.122
2014 Venook AP, Arcila ME, Benson AB, Berry DA, Camidge DR, Carlson RW, Choueiri TK, Guild V, Kalemkerian GP, Kurzrock R, Lovly CM, McKee AE, Morgan RJ, Olszanski AJ, Redman MW, et al. NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1629-49. PMID 25361808 DOI: 10.6004/Jnccn.2014.0161  0.121
2015 Kummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ, Szabo PM, Youn A, Chen AP, Ji J, Allen DE, Lih CJ, Mehaffey MG, et al. Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1574-82. PMID 25589624 DOI: 10.1158/1078-0432.CCR-14-2565  0.121
2001 Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems Proceedings of the National Academy of Sciences of the United States of America. 98: 9742-9747. PMID 11481446 DOI: 10.1073/Pnas.171251798  0.121
2018 Gordeeva J, Morozova N, Sierro N, Isaev A, Sinkunas T, Tsvetkova K, Matlashov M, Truncaite L, Morgan RD, Ivanov NV, Siksnys V, Zeng L, Severinov K. BREX system of Escherichia coli distinguishes self from non-self by methylation of a specific DNA site. Nucleic Acids Research. PMID 30418590 DOI: 10.1093/nar/gky1125  0.121
2012 Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, Morgan RA, Saunders T, Laheru DA, Herman JM, Hruban RH, Klein AP, Jones S, Velculescu V, Wolfgang CL, et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6339-47. PMID 22991414 DOI: 10.1158/1078-0432.Ccr-12-1215  0.12
2011 Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC, Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H. Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1090-8. PMID 21364037 DOI: 10.1158/1078-0432.CCR-10-2410  0.12
2024 Zuley ML, Silverstein J, Logue D, Morgan RS, Bhargava R, McAuliffe PF, Brufsky AM, Bandos AI, Nishikawa RM. Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. Jco Clinical Cancer Informatics. 8: e2300193. PMID 38621193 DOI: 10.1200/CCI.23.00193  0.12
2014 Morgan RG, Ridsdale J, Tonks A, Darley RL. Factors affecting the nuclear localization of β-catenin in normal and malignant tissue. Journal of Cellular Biochemistry. 115: 1351-61. PMID 24610469 DOI: 10.1002/jcb.24803  0.12
2019 Morgan RA, Unti MJ, Aleshe B, Brown D, Osborne KS, Koziol C, Smith OB, O'Brien R, Tam C, Miyahira E, Ruiz M, Quintos JP, Senadheera S, Hollis RP, Kohn DB. Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31628051 DOI: 10.1016/J.Ymthe.2019.09.020  0.12
2002 Morgan R. A common element in epidermal expression? Trends in Genetics : Tig. 18: 184-5. PMID 11932018 DOI: 10.1016/s0168-9525(01)02617-8  0.12
2013 Nielsen TH, Johnson N, Garnier N, Kwan S, Yao L, Cocolakis E, Hébert J, Morgan RA, Paquet E, Callahan KP, Jordan CT, Assouline S, Miller WH, Mann KK. Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient. Frontiers in Pharmacology. 4: 9. PMID 23408639 DOI: 10.3389/Fphar.2013.00009  0.119
2012 Pandha H, Sorensen KD, Orntoft TF, Langley S, Hoyer S, Borre M, Morgan R. Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer. Bju International. 110: E287-92. PMID 22583908 DOI: 10.1111/j.1464-410X.2012.11208.x  0.119
2015 Kilbaugh TJ, Sutton RM, Karlsson M, Hansson MJ, Naim MY, Morgan RW, Bratinov G, Lampe JW, Nadkarni VM, Becker LB, Margulies SS, Berg RA. Persistently Altered Brain Mitochondrial Bioenergetics After Apparently Successful Resuscitation From Cardiac Arrest. Journal of the American Heart Association. 4. PMID 26370446 DOI: 10.1161/Jaha.115.002232  0.119
2008 Heemskerk B, Liu K, Dudley ME, Johnson LA, Kaiser A, Downey S, Zheng Z, Shelton TE, Matsuda K, Robbins PF, Morgan RA, Rosenberg SA. Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2. Human Gene Therapy. 19: 496-510. PMID 18444786 DOI: 10.1089/hum.2007.0171  0.118
2014 Park TS, Abate-Daga D, Zhang L, Zheng Z, Morgan RA. Gamma-retroviral vector design for the co-expression of artificial microRNAs and therapeutic proteins. Nucleic Acid Therapeutics. 24: 356-63. PMID 25019196 DOI: 10.1089/nat.2014.0486  0.118
2015 Morgan RK, Cohen MS. A Clickable Aminooxy Probe for Monitoring Cellular ADP-Ribosylation. Acs Chemical Biology. PMID 25978521 DOI: 10.1021/Acschembio.5B00213  0.118
2015 Justice J, Malhotra S, Ruano M, Li Y, Zavala G, Lee N, Morgan R, Beemon K. The MET gene is a common integration target in avian leukosis virus subgroup J-induced chicken hemangiomas. Journal of Virology. 89: 4712-9. PMID 25673726 DOI: 10.1128/Jvi.03225-14  0.118
2013 Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KAT, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, ... ... Morgan R, et al. Erratum: Corrigendum: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma Nature. 494: 390-390. DOI: 10.1038/Nature11864  0.118
2021 Connell SP, Mills R, Pandha H, Morgan R, Cooper CS, Clark J, Brewer DS, The Movember Gap Urine Biomarker Consortium. Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy. Cancers. 13. PMID 33925381 DOI: 10.3390/cancers13092102  0.117
2013 Morgan RA. Risky business: target choice in adoptive cell therapy. Blood. 122: 3392-4. PMID 24235126 DOI: 10.1182/blood-2013-09-527622  0.117
1992 Cornetta K, Morgan RA, Gillio A, Sturm S, Baltrucki L, O'Reilly R, Anderson WF. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. Human Gene Therapy. 2: 215-9. PMID 1661171 DOI: 10.1089/HUM.1991.2.3-215  0.116
2006 Samuelson JC, Morgan RD, Benner JS, Claus TE, Packard SL, Xu SY. Engineering a rare-cutting restriction enzyme: genetic screening and selection of NotI variants. Nucleic Acids Research. 34: 796-805. PMID 16456032 DOI: 10.1093/nar/gkj483  0.116
1987 Morgan RA, Huang RC. Post-transcriptional regulation and DNA undermethylation of intracisternal A particle genes in embryonal carcinoma cell lines. Developmental Genetics. 8: 123-33. PMID 3139347 DOI: 10.1002/DVG.1020080302  0.116
2010 John J, Ismail M, Riley C, Askham J, Morgan R, Melcher A, Pandha H. Differential effects of Paclitaxel on dendritic cell function. Bmc Immunology. 11: 14. PMID 20302610 DOI: 10.1186/1471-2172-11-14  0.115
2000 Mautino MR, Morgan RA. Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA. Human Gene Therapy. 11: 2025-37. PMID 11020801 DOI: 10.1089/10430340050143444  0.114
2003 Morgan R. The circadian gene Clock is required for the correct early expression of the head specific gene Otx2. The International Journal of Developmental Biology. 46: 999-1004. PMID 12533023  0.114
2022 Arunachalam E, Rogers W, Simpson GR, Möller-Levet C, Bolton G, Ismael M, Smith C, Keegen K, Bagwan I, Brend T, Short SC, Hong B, Otani Y, Kaur B, Annels N, ... Morgan R, et al. HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. Bmc Cancer. 22: 400. PMID 35418059 DOI: 10.1186/s12885-022-09466-8  0.114
1996 Bunnell BA, Morgan RA. Gene therapy for HIV infection Drugs of Today. 32: 209-224. DOI: 10.1002/0471223875.Ch11  0.114
2006 Cohen CJ, Zheng Z, Bray R, Zhao Y, Sherman LA, Rosenberg SA, Morgan RA. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. The Journal of Immunology. 177: 5746-5746. DOI: 10.4049/jimmunol.177.8.5746  0.114
1993 Morgan RA, Nussbaum O, Muenchau DD, Shu L, Couture L, Anderson WF. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. Journal of Virology. 67: 4712-21. PMID 8331726 DOI: 10.1128/jvi.67.8.4712-4721.1993  0.113
2013 Morgan RA. Faster, cheaper, safer, T-cell engineering. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 1-2. PMID 23211627 DOI: 10.1097/CJI.0b013e3182791257  0.113
1998 Donahue RE, Bunnell BA, Zink MC, Metzger ME, Westro RP, Kirby MR, Unangst T, Clements JE, Morgan RA. Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nature Medicine. 4: 181-6. PMID 9461191 DOI: 10.1038/Nm0298-181  0.113
2002 Lozier JN, Csako G, Mondoro TH, Krizek DM, Metzger ME, Costello R, Vostal JG, Rick ME, Donahue RE, Morgan RA. Toxicity of a first-generation adenoviral vector in rhesus macaques. Human Gene Therapy. 13: 113-24. PMID 11779415 DOI: 10.1089/10430340152712665  0.113
2011 Dunican E, Uzbeck M, Clince J, Toner S, Royston D, Logan MP, Breathnach O, Young V, Linnane SI, Morgan RK. Outcomes of patients presenting to a dedicated rapid access lung cancer clinic. Irish Medical Journal. 104: 265-8. PMID 22132593  0.113
2015 Liu L, Patel B, Ghanem MH, Bundoc V, Zheng Z, Morgan RA, Rosenberg SA, Dey B, Berger EA. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity. Journal of Virology. 89: 6685-94. PMID 25878112 DOI: 10.1128/JVI.00474-15  0.113
1984 Wujcik KM, Morgan RA, Huang RC. Transcription of intracisternal A-particle genes in mouse myeloma and Ltk- cells. Journal of Virology. 52: 29-36. PMID 6481855 DOI: 10.1128/jvi.52.1.29-36.1984  0.112
2016 Carter-O'Connell I, Jin H, Morgan RK, Zaja R, David LL, Ahel I, Cohen MS. Identifying Family-Member-Specific Targets of Mono-ARTDs by Using a Chemical Genetics Approach. Cell Reports. PMID 26774478 DOI: 10.1016/J.Celrep.2015.12.045  0.11
2005 Hsu C, Hughes MS, Zheng Z, Bray RB, Rosenberg SA, Morgan RA. Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine. Journal of Immunology (Baltimore, Md. : 1950). 175: 7226-34. PMID 16301627 DOI: 10.4049/Jimmunol.175.11.7226  0.109
2012 Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray H, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, et al. Ovarian cancer, version 3.2012. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 1339-49. PMID 23138163 DOI: 10.6004/Jnccn.2012.0140  0.109
2015 Seib KL, Jen FE, Tan A, Scott AL, Kumar R, Power PM, Chen LT, Wu HJ, Wang AH, Hill DM, Luyten YA, Morgan RD, Roberts RJ, Maiden MC, Boitano M, et al. Specificity of the ModA11, ModA12 and ModD1 epigenetic regulator N(6)-adenine DNA methyltransferases of Neisseria meningitidis. Nucleic Acids Research. 43: 4150-62. PMID 25845594 DOI: 10.1093/Nar/Gkv219  0.109
2014 Kitko CL, Levine JE, Storer BE, Chai X, Fox DA, Braun TM, Couriel DR, Martin PJ, Flowers ME, Hansen JA, Chang L, Conlon M, Fiema BJ, Morgan R, Pongtornpipat P, et al. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. Blood. 123: 786-93. PMID 24363401 DOI: 10.1182/blood-2013-08-520072  0.107
2016 Certo MT, Morgan RA. Salient Features of Endonuclease Platforms for Therapeutic Genome Editing. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26796671 DOI: 10.1038/mt.2016.21  0.106
2010 Paul RF, Morgan RA, Feldman SA, Yang JC, Dudley ME, Li YF, El-Gamil M, Schwarz SL, Rosenberg SA. Abstract LB-175: Tumor regression in patients with metastatic synovial sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-175  0.106
2018 Kumar S, Karmakar BC, Nagarajan D, Mukhopadhyay AK, Morgan RD, Rao DN. N4-cytosine DNA methylation regulates transcription and pathogenesis in Helicobacter pylori. Nucleic Acids Research. PMID 29481677 DOI: 10.1093/nar/gky126  0.106
2016 El-Tanani M, Dakir el-H, Raynor B, Morgan R. Mechanisms of Nuclear Export in Cancer and Resistance to Chemotherapy. Cancers. 8. PMID 26985906 DOI: 10.3390/cancers8030035  0.106
1998 Chen L, Nelson DM, Zheng Z, Morgan RA. Ex vivo fibroblast transduction in rabbits results in long-term (> 600 days) factor IX expression in a small percentage of animals Human Gene Therapy. 9: 2341-2351. PMID 9829533 DOI: 10.1089/HUM.1998.9.16-2341  0.106
2014 Carter-O'Connell I, Jin H, Morgan RK, David LL, Cohen MS. Engineering the substrate specificity of ADP-ribosyltransferases for identifying direct protein targets. Journal of the American Chemical Society. 136: 5201-4. PMID 24641686 DOI: 10.1021/Ja412897A  0.105
1995 Ahearne PM, Morgan RA, Sebastian MW, Bolognesi DP, Weinhold KJ. Multiple CTL Specificities against Autologous HIV-1-Infected BLCLs Cellular Immunology. 161: 34-41. PMID 7867083 DOI: 10.1006/cimm.1995.1006  0.105
2002 Kang EM, de Witte M, Malech H, Morgan RA, Phang S, Carter C, Leitman SF, Childs R, Barrett AJ, Little R, Tisdale JF. Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood. 99: 698-701. PMID 11781257 DOI: 10.1182/BLOOD.V99.2.698  0.105
1990 Cornetta K, Moen RC, Culver K, Morgan RA, McLachlin JR, Sturm S, Selegue J, London W, Blaese RM, Anderson WF. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates Human Gene Therapy. 1: 15-30. PMID 1964393 DOI: 10.1089/Hum.1990.1.1-15  0.104
1999 Lozier JN, Metzger ME, Donahue RE, Morgan RA. Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting Toxicity Blood. 94: 3968-3975. DOI: 10.1182/BLOOD.V94.12.3968.424K43_3968_3975  0.103
2013 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. Plos One. 8: e64216. PMID 23717571 DOI: 10.1371/journal.pone.0064216  0.103
2021 Picton DM, Luyten YA, Morgan RD, Nelson A, Smith DL, Dryden DTF, Hinton JCD, Blower TR. The phage defence island of a multidrug resistant plasmid uses both BREX and type IV restriction for complementary protection from viruses. Nucleic Acids Research. PMID 34657954 DOI: 10.1093/nar/gkab906  0.103
2013 Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood. 121: 1165-74. PMID 23243285 DOI: 10.1182/Blood-2012-06-438002  0.103
1999 Morgan RA. Genetic strategies to inhibit HIV. Molecular Medicine Today. 5: 454-8. PMID 10498914 DOI: 10.1016/S1357-4310(99)01542-7  0.102
1999 Lozier JN, Metzger ME, Donahue RE, Morgan RA. The Rhesus Macaque as an Animal Model for Hemophilia B Gene Therapy Blood. 93: 1875-1881. DOI: 10.1182/BLOOD.V93.6.1875.406K16_1875_1881  0.102
2015 Dunn DM, Woodford MR, Truman AW, Jensen SM, Schulman J, Caza T, Remillard TC, Loiselle D, Wolfgeher D, Blagg BS, Franco L, Haystead TA, Daturpalli S, Mayer MP, Trepel JB, ... Morgan RM, et al. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells. Cell Reports. 12: 1006-18. PMID 26235616 DOI: 10.1016/J.Celrep.2015.07.004  0.102
2004 Theokli C, Morsi El-Kadi AS, Morgan R. TALE class homeodomain gene Irx5 is an immediate downstream target for Hoxb4 transcriptional regulation. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 227: 48-55. PMID 12701098 DOI: 10.1002/dvdy.10287  0.102
2006 Morgan R. Engrailed: complexity and economy of a multi-functional transcription factor. Febs Letters. 580: 2531-3. PMID 16674951 DOI: 10.1016/j.febslet.2006.04.053  0.101
2000 Mautino MR, Keiser N, Morgan RA. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element. Gene Therapy. 7: 1421-1424. PMID 10981670 DOI: 10.1038/Sj.Gt.3301262  0.101
1995 VandenDriessche T, Chuah MK, Chiang L, Chang HK, Ensoli B, Morgan RA. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes. Journal of Virology. 69: 4045-52. PMID 7769662 DOI: 10.1128/jvi.69.7.4045-4052.1995  0.1
2023 Erkes A, Grove RP, Žarković M, Krautwurst S, Koebnik R, Morgan RD, Wilson GG, Hölzer M, Marz M, Boch J, Grau J. Assembling highly repetitive Xanthomonas TALomes using Oxford Nanopore sequencing. Bmc Genomics. 24: 151. PMID 36973643 DOI: 10.1186/s12864-023-09228-1  0.1
2003 Roberts RJ, Belfort M, Bestor T, Bhagwat AS, Bickle TA, Bitinaite J, Blumenthal RM, Degtyarev SKh, Dryden DT, Dybvig K, Firman K, Gromova ES, Gumport RI, Halford SE, Hattman S, ... ... Morgan RD, et al. A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes. Nucleic Acids Research. 31: 1805-12. PMID 12654995 DOI: 10.1093/Nar/Gkg274  0.099
2013 Morgan RG, Liddiard K, Pearn L, Pumford SL, Burnett AK, Darley RL, Tonks A. γ-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation. Leukemia. 27: 2096-100. PMID 23545990 DOI: 10.1038/leu.2013.96  0.099
2004 Morgan R, Sohal J, Paleja M, Pettengell R. Pbx genes are required in Xenopus lens development International Journal of Developmental Biology. 48: 623-627. PMID 15470634 DOI: 10.1387/ijdb.041887rm  0.099
1998 Donahue RE, Bunnell BA, Zink MC, Metzger ME, Westro RP, Kirby MR, Unangst T, Clements JE, Morgan R. Erratum: Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes (Nature Medicine (1998) 4 (181-186)) Nature Medicine. 4. DOI: 10.1038/Nm0598-633  0.098
2015 Hu X, Wang Y, Hao LY, Liu X, Lesch CA, Sanchez BM, Wendling JM, Morgan RW, Aicher TD, Carter LL, Toogood PL, Glick GD. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists. Nature Chemical Biology. 11: 141-7. PMID 25558972 DOI: 10.1038/Nchembio.1714  0.098
2015 Hirte H, Lheureux S, Fleming GF, Sugimoto A, Morgan R, Biagi J, Wang L, McGill S, Ivy SP, Oza AM. A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia. Gynecologic Oncology. 138: 55-61. PMID 25895616 DOI: 10.1016/j.ygyno.2015.04.009  0.096
2003 Thickett C, Morgan R. Hoxc-8 expression shows left-right asymmetry in the posterior lateral plate mesoderm. Gene Expression Patterns : Gep. 2: 5-6. PMID 12617829 DOI: 10.1016/s0925-4773(02)00353-2  0.096
2012 Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. American Journal of Clinical Pathology. 138: 356-66. PMID 22912351 DOI: 10.1309/AJCPVT7LC4CRPZSK  0.096
2022 Picton DM, Harling-Lee JD, Duffner SJ, Went SC, Morgan RD, Hinton JCD, Blower TR. A widespread family of WYL-domain transcriptional regulators co-localizes with diverse phage defence systems and islands. Nucleic Acids Research. 50: 5191-5207. PMID 35544231 DOI: 10.1093/nar/gkac334  0.096
2013 Errico MC, Felicetti F, Bottero L, Mattia G, Boe A, Felli N, Petrini M, Bellenghi M, Pandha HS, Calvaruso M, Tripodo C, Colombo MP, Morgan R, Carè A. The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. International Journal of Cancer. Journal International Du Cancer. 133: 879-92. PMID 23400877 DOI: 10.1002/ijc.28097  0.096
2014 Castonguay V, Lheureux S, Welch S, Mackay HJ, Hirte H, Fleming G, Morgan R, Wang L, Blattler C, Ivy PS, Oza AM. A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: a study of the Princess Margaret, Chicago and California Consortia. Gynecologic Oncology. 134: 274-80. PMID 24882554 DOI: 10.1016/j.ygyno.2014.05.016  0.095
2014 Ando H, Natsume A, Senga T, Watanabe R, Ito I, Ohno M, Iwami K, Ohka F, Motomura K, Kinjo S, Ito M, Saito K, Morgan R, Wakabayashi T. Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma. Cancer Chemotherapy and Pharmacology. 73: 53-60. PMID 24141373 DOI: 10.1007/s00280-013-2316-5  0.095
2015 Morgan RK, Batra H, Gaerig VC, Hockings J, Brooks TA. Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator. Biochimica Et Biophysica Acta. PMID 26597160 DOI: 10.1016/J.Bbagrm.2015.11.004  0.095
2013 McGrath SE, Michael A, Morgan R, Pandha H. EN2: a novel prostate cancer biomarker. Biomarkers in Medicine. 7: 893-901. PMID 24266821 DOI: 10.2217/bmm.13.115  0.095
2013 Sun V, Otis-Green S, Morgan R, Wakabayashi M, Hakim A, Callado ME, Yang E, Ferrell B, Grant M. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer. European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society. 17: 375-80. PMID 23153453 DOI: 10.1016/J.Ejon.2012.10.005  0.095
2020 Zhang L, Davies JS, Serna C, Yu Z, Restifo NP, Rosenberg SA, Morgan RA, Hinrichs CS. Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models. Journal For Immunotherapy of Cancer. 8. PMID 31959727 DOI: 10.1136/Jitc-2019-000210  0.094
2015 Morgan R, Endres J, Behbahani-Nejad N, Phillips K, Ruth JH, Friday SC, Edhayan G, Lanigan T, Urquhart A, Chung KC, Fox DA. Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity. Arthritis & Rheumatology (Hoboken, N.J.). 67: 74-85. PMID 25219368 DOI: 10.1002/Art.38878  0.094
2013 Morgan RG, Pearn L, Liddiard K, Pumford SL, Burnett AK, Tonks A, Darley RL. γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin. Leukemia. 27: 336-43. PMID 22858986 DOI: 10.1038/leu.2012.221  0.093
2005 Morgan R. Pax6 is a direct, positively regulated target of the circadian gene Clock. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 230: 643-50. PMID 15254898 DOI: 10.1002/dvdy.20097  0.093
2014 Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis ME, Yen Y. Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proceedings of the National Academy of Sciences of the United States of America. 111: 11449-54. PMID 25049380 DOI: 10.1073/Pnas.1411393111  0.093
2014 Clark GB, Morgan RO, Fernandez MP, Salmi ML, Roux SJ. Breakthroughs spotlighting roles for extracellular nucleotides and apyrases in stress responses and growth and development. Plant Science : An International Journal of Experimental Plant Biology. 225: 107-16. PMID 25017166 DOI: 10.1016/j.plantsci.2014.06.002  0.093
1996 Morgan RA, Walker R. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. Human Gene Therapy. 7: 1281-306. PMID 8793552 DOI: 10.1089/HUM.1996.7.10-1281  0.092
2013 Uemura M, Morgan R, Mendelsohn M, Kagan J, Saavedra C, Leong L. Enhancing quality improvements in cancer care through CME activities at a nationally recognized cancer center. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 28: 215-20. PMID 23608956 DOI: 10.1007/s13187-013-0467-z  0.092
2018 Holland CJ, MacLachlan BJ, Bianchi V, Hesketh SJ, Morgan R, Vickery O, Bulek AM, Fuller A, Godkin A, Sewell AK, Rizkallah PJ, Wells S, Cole DK. and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop Flexibility. Frontiers in Immunology. 9: 674. PMID 29696015 DOI: 10.3389/fimmu.2018.00674  0.092
2013 Nurgalieva ZZ, Franzini L, Morgan R, Vernon SW, Liu CC, Du XL. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival. Medical Oncology (Northwood, London, England). 30: 691. PMID 23975632 DOI: 10.1007/S12032-013-0691-8  0.092
2020 Farooqi F, Dhawan N, Morgan R, Dinh J, Nedd K, Yatzkan G. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review. Tropical Medicine and Infectious Disease. 5. PMID 32635353 DOI: 10.3390/tropicalmed5030112  0.091
2013 Otis-Green S, Wakabayashi MT, Morgan R, Hakim A, Ferrell B, Sun V, Yang E, Grant M. Palliative care opportunities for women with advanced ovarian cancer associated with intraperitoneal chemotherapy. Journal of Palliative Medicine. 16: 44-53. PMID 23272673 DOI: 10.1089/Jpm.2012.0174  0.091
2014 Beane JD, Lee GK, Zheng Z, Gandhi N, Abate-Daga D, Bharathan M, Black M, Mendel M, Yu Z, Kassim SH, Chandran S, Giedlin M, Ando D, Rebar E, Reik A, ... ... Morgan RA, et al. Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P2  0.091
1996 Cornetta K, Srour EF, Moore A, Davidson A, Broun ER, Hromas R, Moen RC, Morgan RA, Rubin L, Anderson WF, Hoffman R, Tricot G. Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia. Human Gene Therapy. 7: 1323-9. PMID 8818719 DOI: 10.1089/Hum.1996.7.11-1323  0.091
2013 Killick E, Morgan R, Launchbury F, Bancroft E, Page E, Castro E, Kote-Jarai Z, Aprikian A, Blanco I, Clowes V, Domchek S, Douglas F, Eccles D, Evans DG, Harris M, et al. Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men. Scientific Reports. 3: 2059. PMID 23792811 DOI: 10.1038/Srep02059  0.091
2014 Ng S, Morgan RO, Walder A, Biswas J, Bass DM, Judge KS, Snow AL, Wilson N, Kunik ME. Functional Decline Predicts Emergency Department Use in Veterans With Dementia. American Journal of Alzheimer's Disease and Other Dementias. 29: 362-371. PMID 24413540 DOI: 10.1177/1533317513518655  0.091
2012 Chao J, Synold TW, Morgan RJ, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, et al. A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. Cancer Chemotherapy and Pharmacology. 69: 835-43. PMID 22105720 DOI: 10.1007/S00280-011-1779-5  0.09
2013 Morgan RG, Ives SJ, Lesniewski LA, Cawthon RM, Andtbacka RH, Noyes RD, Richardson RS, Donato AJ. Age-related telomere uncapping is associated with cellular senescence and inflammation independent of telomere shortening in human arteries. American Journal of Physiology. Heart and Circulatory Physiology. 305: H251-8. PMID 23666675 DOI: 10.1152/Ajpheart.00197.2013  0.09
2013 Septer S, Slowik V, Morgan R, Dai H, Attard T. Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals. Hereditary Cancer in Clinical Practice. 11: 13. PMID 24093640 DOI: 10.1186/1897-4287-11-13  0.089
2017 Skowron PM, Anton BP, Czajkowska E, Zebrowska J, Sulecka E, Krefft D, Jezewska-Frackowiak J, Zolnierkiewicz O, Witkowska M, Morgan RD, Wilson GG, Fomenkov A, Roberts RJ, Zylicz-Stachula A. The third restriction-modification system from Thermus aquaticus YT-1: solving the riddle of two TaqII specificities. Nucleic Acids Research. 45: 9005-9018. PMID 28911108 DOI: 10.1093/Nar/Gkx599  0.088
1990 Weng DE, Morgan RA, Gearhart JD. Estimates of mRNA abundance in the mouse blastocyst based on cDNA library analysis. Molecular Reproduction and Development. 1: 233-41. PMID 2483515 DOI: 10.1002/Mrd.1080010403  0.088
2014 Donato AJ, Henson GD, Hart CR, Layec G, Trinity JD, Bramwell RC, Enz RA, Morgan RG, Reihl KD, Hazra S, Walker AE, Richardson RS, Lesniewski LA. The impact of ageing on adipose structure, function and vasculature in the B6D2F1 mouse: evidence of significant multisystem dysfunction. The Journal of Physiology. 592: 4083-96. PMID 25038241 DOI: 10.1113/Jphysiol.2014.274175  0.088
2010 Shen BW, Heiter DF, Chan SH, Wang H, Xu SY, Morgan RD, Wilson GG, Stoddard BL. Unusual target site disruption by the rare-cutting HNH restriction endonuclease PacI. Structure (London, England : 1993). 18: 734-43. PMID 20541511 DOI: 10.1016/J.Str.2010.03.009  0.088
2012 Bernard A, Lubbers LS, Tanis KQ, Luo R, Podtelezhnikov AA, Finney EM, McWhorter MM, Serikawa K, Lemon T, Morgan R, Copeland C, Smith K, Cullen V, Davis-Turak J, Lee CK, et al. Transcriptional architecture of the primate neocortex. Neuron. 73: 1083-99. PMID 22445337 DOI: 10.1016/J.Neuron.2012.03.002  0.088
2014 Benjamin R, Zhai J, Morgan R, Prakash N. Trismus and diffuse polymyalgia: an unusual presentation of recurrent metastatic ovarian cancer. Bmj Case Reports. 2014. PMID 24835804 DOI: 10.1136/Bcr-2013-203361  0.088
1995 MORGAN RA, VANDENDRIESSCHE T, CHUAH M, BUNNELL B, BRESSLER P, WALKER R, LANE C, BLAESE RM. Comparison of Anti-HIV-1 Retroviral Vectors and Their Use in a Gene Therapy Trial in Identical Twins Journal of Immunotherapy. 17: 124. DOI: 10.1097/00002371-199502000-00046  0.087
2015 McGrath SE, Michael A, Morgan R, Pandha H. EN2 in Prostate Cancer. Advances in Clinical Chemistry. 71: 47-76. PMID 26411411 DOI: 10.1016/bs.acc.2015.06.002  0.087
2002 Lozier JN, Dutra A, Pak E, Zhou N, Zheng Z, Nichols TC, Bellinger DA, Read M, Morgan RA. The Chapel Hill hemophilia a dog colony exhibits a factor VIII gene inversion Proceedings of the National Academy of Sciences of the United States of America. 99: 12991-12996. PMID 12242334 DOI: 10.1073/pnas.192219599  0.086
2015 De Paoli M, Perco P, Mühlberger I, Lukas A, Pandha H, Morgan R, Feng GJ, Marquette C. Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 20: 328-37. PMID 26329530 DOI: 10.3109/1354750X.2015.1068867  0.086
2017 Cooper LP, Roberts GA, White JH, Luyten YA, Bower EK, Morgan RD, Roberts RJ, Lindsay JA, Dryden DT. DNA target recognition domains in the Type I restriction and modification systems of Staphylococcus aureus. Nucleic Acids Research. PMID 28180279 DOI: 10.1093/Nar/Gkx067  0.086
2015 Darda L, Hakami F, Morgan R, Murdoch C, Lambert DW, Hunter KD. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma. Plos One. 10: e0122285. PMID 25860510 DOI: 10.1371/journal.pone.0122285  0.086
2013 Emohare O, Peterson E, Slinkard N, Janus S, Morgan R. Occam paradox? A variation of tapia syndrome and an unreported complication of guidewire-assisted pedicle screw insertion. Evidence-Based Spine-Care Journal. 4: 132-6. PMID 24436711 DOI: 10.1055/s-0033-1357355  0.085
2018 Bower EKM, Cooper LP, Roberts GA, White JH, Luyten Y, Morgan RD, Dryden DTF. A model for the evolution of prokaryotic DNA restriction-modification systems based upon the structural malleability of Type I restriction-modification enzymes. Nucleic Acids Research. PMID 30165537 DOI: 10.1093/nar/gky760  0.085
2020 Hajibandeh S, Hajibandeh S, Morgan R, Maw A. The incidence of right-sided colon cancer in patients aged over 40 years with acute appendicitis: A systematic review and meta-analysis. International Journal of Surgery (London, England). PMID 32387215 DOI: 10.1016/j.ijsu.2020.04.065  0.084
2023 Kelly A, Went SC, Mariano G, Shaw LP, Picton DM, Duffner SJ, Coates I, Herdman-Grant R, Gordeeva J, Drobiazko A, Isaev A, Lee YJ, Luyten Y, Morgan RD, Weigele P, et al. Diverse Durham collection phages demonstrate complex BREX defense responses. Applied and Environmental Microbiology. e0062323. PMID 37668405 DOI: 10.1128/aem.00623-23  0.084
1999 Nelson DM, Wahlfors JJ, Chen L, Onodera M, Morgan RA. Characterization of diverse viral vector preparations, using a simple and rapid whole-virion dot-blot method. Human Gene Therapy. 9: 2401-5. PMID 9829539 DOI: 10.1089/HUM.1998.9.16-2401  0.084
2012 Morgan RJ. Thinking outside the box about screening for ovarian cancer: the nose knows! Journal of the National Comprehensive Cancer Network : Jnccn. 10: 795-6. PMID 22679121  0.083
2012 Clark GB, Morgan RO, Fernandez MP, Roux SJ. Evolutionary adaptation of plant annexins has diversified their molecular structures, interactions and functional roles. The New Phytologist. 196: 695-712. PMID 22994944 DOI: 10.1111/j.1469-8137.2012.04308.x  0.083
2010 Kushner EJ, MacEneaney OJ, Morgan RG, Van Engelenburg AM, Van Guilder GP, DeSouza CA. CD31+ T cells represent a functionally distinct vascular T cell phenotype. Blood Cells, Molecules & Diseases. 44: 74-8. PMID 19897387 DOI: 10.1016/J.Bcmd.2009.10.009  0.083
2015 Donato AJ, Morgan RG, Walker AE, Lesniewski LA. Cellular and molecular biology of aging endothelial cells. Journal of Molecular and Cellular Cardiology. PMID 25655936 DOI: 10.1016/J.Yjmcc.2015.01.021  0.083
2015 Morgan RK, Carter-O'Connell I, Cohen MS. Selective inhibition of PARP10 using a chemical genetics strategy. Bioorganic & Medicinal Chemistry Letters. 25: 4770-3. PMID 26231158 DOI: 10.1016/J.Bmcl.2015.07.033  0.083
2009 Morgan RD, Luyten YA. Rational engineering of type II restriction endonuclease DNA binding and cleavage specificity. Nucleic Acids Research. 37: 5222-33. PMID 19567736 DOI: 10.1093/nar/gkp535  0.082
2012 Fu T, Pappou EP, Guzzetta AA, Jeschke J, Kwak R, Dave P, Hooker CM, Morgan R, Baylin SB, Iacobuzio-Donahue CA, Wolfgang CL, Ahuja N. CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4743-52. PMID 22825585 DOI: 10.1158/1078-0432.CCR-12-0707  0.082
2013 Moore DL, Henke SE, Fedynich AM, Laurenz JC, Morgan R. Acute effects of aflatoxin on northern bobwhites (Colinus virginianus). Journal of Wildlife Diseases. 49: 568-78. PMID 23778606 DOI: 10.7589/2011-12-354  0.081
2014 Taylor K, Kleinhesselink K, George MD, Morgan R, Smallwood T, Hammonds AS, Fuller PM, Saelao P, Alley J, Gibbs AG, Hoshizaki DK, von Kalm L, Fuller CA, Beckingham KM, Kimbrell DA. Toll mediated infection response is altered by gravity and spaceflight in Drosophila. Plos One. 9: e86485. PMID 24475130 DOI: 10.1371/Journal.Pone.0086485  0.08
2012 Murray IA, Clark TA, Morgan RD, Boitano M, Anton BP, Luong K, Fomenkov A, Turner SW, Korlach J, Roberts RJ. The methylomes of six bacteria. Nucleic Acids Research. 40: 11450-62. PMID 23034806 DOI: 10.1093/Nar/Gks891  0.079
2009 Zheng Y, Posfai J, Morgan RD, Vincze T, Roberts RJ. Using shotgun sequence data to find active restriction enzyme genes. Nucleic Acids Research. 37: e1. PMID 18988632 DOI: 10.1093/Nar/Gkn883  0.079
2014 Qin F, Siwik DA, Pimentel DR, Morgan RJ, Biolo A, Tu VH, Kang YJ, Cohen RA, Colucci WS. Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload. American Journal of Physiology. Heart and Circulatory Physiology. 306: H1453-63. PMID 24633550 DOI: 10.1152/ajpheart.00084.2014  0.079
2016 Callahan SJ, Luyten YA, Gupta YK, Wilson GG, Roberts RJ, Morgan RD, Aggarwal AK. Structure of Type IIL Restriction-Modification Enzyme MmeI in Complex with DNA Has Implications for Engineering New Specificities. Plos Biology. 14: e1002442. PMID 27082731 DOI: 10.1371/Journal.Pbio.1002442  0.078
2013 Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Medical Oncology (Northwood, London, England). 30: 419. PMID 23292872 DOI: 10.1007/S12032-012-0419-1  0.078
2014 Morgan RJ. Underserved topics in oncology: the role of physical activity in improving quality of life and decreasing recurrence risk in patients with cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 735-7. PMID 24812140  0.078
1996 BLAESE RM, CULVER K, KOHN D, MORGAN R, MILLER AD, ANDERSON WF, TOURAINE R, RAMSEY WJ, RAM Z, OLDFIELD E. GENE THERAPY Vox Sanguinis. 70: 21-23. DOI: 10.1111/j.1423-0410.1996.tb01362.x  0.077
2012 Destounis SV, Arieno AL, Morgan RC. CAD May Not be Necessary for Microcalcifications in the Digital era, CAD May Benefit Radiologists for Masses. Journal of Clinical Imaging Science. 2: 45. PMID 22919559 DOI: 10.4103/2156-7514.99179  0.077
2013 Fleming JR, Morgan RE, Fyfe PK, Kelly SM, Hunter WN. The architecture of Trypanosoma brucei tubulin-binding cofactor B and implications for function. The Febs Journal. 280: 3270-80. PMID 23627368 DOI: 10.1111/febs.12308  0.077
2021 Murray IA, Luyten YA, Fomenkov A, Dai N, Corrêa IR, Farmerie WG, Clark TA, Korlach J, Morgan RD, Roberts RJ. Structural and functional diversity among Type III restriction-modification systems that confer host DNA protection via methylation of the N4 atom of cytosine. Plos One. 16: e0253267. PMID 34228724 DOI: 10.1371/journal.pone.0253267  0.077
2012 Blows SJ, Morgan R, Dhariwal U, Petts G, Roncaroli F. Pancreatic adenocarcinoma presenting with sudden onset bilateral deafness secondary to metastatic leptomeningeal infiltration. Age and Ageing. 41: 818-9. PMID 22743150 DOI: 10.1093/ageing/afs085  0.077
1999 Statham V, Bittner M, Trent J, Morgan RA. Applying cDNA microarray technology to gene therapy Nature Genetics. 23: 75-75. DOI: 10.1038/14407  0.077
2017 Murray IA, Morgan RD, Luyten Y, Fomenkov A, Corrêa IR, Dai N, Allaw MB, Zhang X, Cheng X, Roberts RJ. The non-specific adenine DNA methyltransferase M.EcoGII. Nucleic Acids Research. PMID 29228259 DOI: 10.1093/Nar/Gkx1191  0.076
2013 Weiss GJ, Chao J, Neidhart JD, Ramanathan RK, Bassett D, Neidhart JA, Choi CH, Chow W, Chung V, Forman SJ, Garmey E, Hwang J, Kalinoski DL, Koczywas M, Longmate J, ... ... Morgan R, et al. First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies. Investigational New Drugs. 31: 986-1000. PMID 23397498 DOI: 10.1007/S10637-012-9921-8  0.076
1988 Bendotti C, Forloni GL, Morgan RA, O'Hara BF, Oster-Granite ML, Reeves RH, Gearhart JD, Coyle JT. Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice. Proceedings of the National Academy of Sciences of the United States of America. 85: 3628-32. PMID 2897124 DOI: 10.1073/Pnas.85.10.3628  0.076
2014 Caron E, Morgan R, Wheless JW. An unusual cause of flaccid paralysis and coma: baclofen overdose. Journal of Child Neurology. 29: 555-9. PMID 23481445 DOI: 10.1177/0883073813479668  0.076
2016 Morgan RD, Luyten YA, Johnson SA, Clough EM, Clark TA, Roberts RJ. Novel m4C modification in type I restriction-modification systems. Nucleic Acids Research. PMID 27580720 DOI: 10.1093/Nar/Gkw743  0.076
2002 Soundararajan M, Chang Z, Morgan RD, Heslop P, Connolly BA. DNA binding and recognition by the IIs restriction endonuclease MboII Journal of Biological Chemistry. 277: 887-895. PMID 11606594 DOI: 10.1074/jbc.M109100200  0.076
2014 Shi J, Pagliaccia D, Morgan R, Qiao Y, Pan S, Vidalakis G, Ma W. Novel diagnosis for citrus stubborn disease by detection of a spiroplasma citri-secreted protein. Phytopathology. 104: 188-95. PMID 23931112 DOI: 10.1094/Phyto-06-13-0176-R  0.075
2003 Wahlfors J, Morgan RA. Semliki Forest virus vectors for gene transfer. Methods in Molecular Medicine. 76: 493-502. PMID 12526181 DOI: 10.1385/1-59259-304-6:493  0.075
2015 Morgan RJ, Synold TW, Longmate JA, Quinn DI, Gandara D, Lenz HJ, Ruel C, Xi B, Lewis MD, Colevas AD, Doroshow J, Newman EM. Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial. Cancer Chemotherapy and Pharmacology. PMID 26362045 DOI: 10.1007/s00280-015-2868-7  0.075
2011 Callahan SJ, Morgan RD, Jain R, Townson SA, Wilson GG, Roberts RJ, Aggarwal AK. Crystallization and preliminary crystallographic analysis of the type IIL restriction enzyme MmeI in complex with DNA. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 67: 1262-5. PMID 22102043 DOI: 10.1107/S1744309111028041  0.075
2014 Destounis SV, Arieno AL, Morgan RC, Cavanaugh D, Seifert PJ, Murphy PF, Somerville PA. Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility. Ajr. American Journal of Roentgenology. 202: 928-32. PMID 24660726 DOI: 10.2214/AJR.13.11194  0.075
2004 Pingoud V, Sudina A, Geyer H, Bujnicki JM, Lurz R, Lüder G, Morgan R, Kubareva E, Pingoud A. Specificity changes in the evolution of type II restriction endonucleases: a biochemical and bioinformatic analysis of restriction enzymes that recognize unrelated sequences. The Journal of Biological Chemistry. 280: 4289-98. PMID 15563460 DOI: 10.1074/JBC.M409020200  0.074
2012 Morgan RA. Live and let die: a new suicide gene therapy moves to the clinic. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 11-3. PMID 22319780 DOI: 10.1038/mt.2011.273  0.074
2016 Blow MJ, Clark TA, Daum CG, Deutschbauer AM, Fomenkov A, Fries R, Froula J, Kang DD, Malmstrom RR, Morgan RD, Posfai J, Singh K, Visel A, Wetmore K, Zhao Z, et al. The Epigenomic Landscape of Prokaryotes. Plos Genetics. 12: e1005854. PMID 26870957 DOI: 10.1371/Journal.Pgen.1005854  0.074
2015 Patel R, Muller-Hulsbeck S, Morgan R, Uberoi R. Vascular Closure Devices in Interventional Radiology Practice. Cardiovascular and Interventional Radiology. PMID 25944150 DOI: 10.1007/s00270-015-1116-1  0.074
2023 Shen BW, Doyle LA, Werther R, Westburg AA, Bies DP, Walter SI, Luyten YA, Morgan RD, Stoddard BL, Kaiser BK. Structure, substrate binding and activity of a unique AAA+ protein: the BrxL phage restriction factor. Nucleic Acids Research. PMID 36794719 DOI: 10.1093/nar/gkad083  0.074
2014 Morgan R, Ensor T. The regulation of private hospitals in Asia. The International Journal of Health Planning and Management. PMID 24820938 DOI: 10.1002/hpm.2257  0.074
2023 Kennedy MA, Hosford CJ, Azumaya CM, Luyten YA, Chen M, Morgan RD, Stoddard BL. Structures, activity and mechanism of the Type IIS restriction endonuclease PaqCI. Nucleic Acids Research. PMID 36987874 DOI: 10.1093/nar/gkad228  0.073
2018 Morgan RG, Donato AJ, Walker AE. Telomere uncapping and vascular aging. American Journal of Physiology. Heart and Circulatory Physiology. PMID 29547021 DOI: 10.1152/Ajpheart.00008.2018  0.073
2013 Fu T, Guzzetta AA, Jeschke J, Vatapalli R, Dave P, Hooker CM, Morgan R, Iacobuzio-Donahue CA, Liu B, Ahuja N. KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma. International Journal of Cancer. Journal International Du Cancer. 132: 2502-9. PMID 23065691 DOI: 10.1002/ijc.27910  0.073
2014 Siskind E, Alex A, Alexander M, Akerman M, Mathew C, Fishbane L, Thomas J, Israel E, Fana M, Evans C, Godwin A, Agorastos S, Mellace B, Rosado J, Rajendran PP, ... ... Morgan RM, et al. Factors associated with completion of pre-kidney transplant evaluations. The International Journal of Angiology : Official Publication of the International College of Angiology, Inc. 23: 23-8. PMID 24627614 DOI: 10.1055/s-0033-1358661  0.072
2015 De Paoli M, Perco P, Mühlberger I, Lukas A, Pandha H, Morgan R, Feng GJ, Marquette C. Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 1-10. PMID 26227542 DOI: 10.3109/1354750X.2015.1068867  0.071
2013 Morgan RM, Steele RJ, Nabi G, McCowan C. Socioeconomic variation and prostate specific antigen testing in the community: a United Kingdom based population study. The Journal of Urology. 190: 1207-12. PMID 23608675 DOI: 10.1016/j.juro.2013.04.044  0.071
2015 Brayley-Morris H, Sorrell A, Revoir AP, Meakin GE, Court DS, Morgan RM. Persistence of DNA from laundered semen stains: Implications for child sex trafficking cases. Forensic Science International. Genetics. 19: 165-71. PMID 26232275 DOI: 10.1016/j.fsigen.2015.07.016  0.071
1993 Morgan RA, Dornsife RE, Anderson WF, Hoover EA. In vitro infection of human bone marrow by feline leukemia viruses. Virology. 193: 439-42. PMID 8382406 DOI: 10.1006/viro.1993.1141  0.071
2012 Mackay HJ, Buckanovich RJ, Hirte H, Correa R, Hoskins P, Biagi J, Martin LP, Fleming GF, Morgan R, Wang L, Polintan R, Oza AM. A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. Gynecologic Oncology. 125: 136-40. PMID 22138373 DOI: 10.1016/j.ygyno.2011.11.042  0.07
2013 Morgan RM, Davies G, Balestri F, Bull PA. The recovery of pollen evidence from documents and its forensic implications. Science & Justice : Journal of the Forensic Science Society. 53: 375-84. PMID 24188338 DOI: 10.1016/j.scijus.2013.03.004  0.07
2012 Donato AJ, Henson GD, Morgan RG, Enz RA, Walker AE, Lesniewski LA. TNF-α impairs endothelial function in adipose tissue resistance arteries of mice with diet-induced obesity. American Journal of Physiology. Heart and Circulatory Physiology. 303: H672-9. PMID 22821989 DOI: 10.1152/Ajpheart.00271.2012  0.07
2013 Ozdemir BA, Chung R, Benson RA, Mailli L, Thompson M, Morgan R, Loftus IM. Embolisation of type 2 endoleaks after endovascular aneurysm repair. The Journal of Cardiovascular Surgery. 54: 485-90. PMID 24013537  0.07
2021 Zatopek KM, Burkhart BW, Morgan RD, Gehring AM, Scott KA, Santangelo TJ, Gardner AF. The Hyperthermophilic Restriction-Modification Systems of Protect Genome Integrity. Frontiers in Microbiology. 12: 657356. PMID 34093470 DOI: 10.3389/fmicb.2021.657356  0.07
2018 Bogdanove AJ, Bohm A, Miller JC, Morgan RD, Stoddard BL. Engineering altered protein-DNA recognition specificity. Nucleic Acids Research. PMID 29718463 DOI: 10.1093/Nar/Gky289  0.069
2009 Morgan RD, Dwinell EA, Bhatia TK, Lang EM, Luyten YA. The MmeI family: type II restriction-modification enzymes that employ single-strand modification for host protection. Nucleic Acids Research. 37: 5208-21. PMID 19578066 DOI: 10.1093/nar/gkp534  0.069
2012 Clark TA, Murray IA, Morgan RD, Kislyuk AO, Spittle KE, Boitano M, Fomenkov A, Roberts RJ, Korlach J. Characterization of DNA methyltransferase specificities using single-molecule, real-time DNA sequencing. Nucleic Acids Research. 40: e29. PMID 22156058 DOI: 10.1093/Nar/Gkr1146  0.069
2015 Earwaker H, Morgan RM, Harris AJ, Hall LJ. Fingermark submission decision-making within a UK fingerprint laboratory: Do experts get the marks that they need? Science & Justice : Journal of the Forensic Science Society. 55: 239-47. PMID 26087871 DOI: 10.1016/j.scijus.2015.01.007  0.069
2015 Newman EM, Morgan RJ, Kummar S, Beumer JH, Blanchard MS, Ruel C, El-Khoueiry AB, Carroll MI, Hou JM, Li C, Lenz HJ, Eiseman JL, Doroshow JH. A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine. Cancer Chemotherapy and Pharmacology. 75: 537-46. PMID 25567350 DOI: 10.1007/s00280-014-2674-7  0.069
1992 Cornetta K, Tricot G, Broun ER, Hromas R, Srour E, Hoffman R, Anderson WF, Moen RC, Morgan RA. Retroviral-mediated gene transfer of bone marrow cells during autologous bone marrow transplantation for acute leukemia. Human Gene Therapy. 3: 305-18. PMID 1643150 DOI: 10.1089/hum.1992.3.3-305  0.069
2009 Pandha HS, Heinemann L, Simpson GR, Melcher A, Prestwich R, Errington F, Coffey M, Harrington KJ, Morgan R. Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6158-66. PMID 19773377 DOI: 10.1158/1078-0432.CCR-09-0796  0.068
2015 Alsanea N, Almadi MA, Abduljabbar AS, Alhomoud S, Alshaban TA, Alsuhaibani A, Alzahrani A, Batwa F, Hassan AH, Hibbert D, Nooh R, Alothman M, Rochwerg B, Alhazzani W, Morgan RL. National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence. Annals of Saudi Medicine. 35: 189-95. PMID 26409792 DOI: 10.5144/0256-4947.2015.189  0.068
2012 Xavier CP, Rastetter RH, Blömacher M, Stumpf M, Himmel M, Morgan RO, Fernandez MP, Wang C, Osman A, Miyata Y, Gjerset RA, Eichinger L, Hofmann A, Linder S, Noegel AA, et al. Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration. Scientific Reports. 2: 241. PMID 22355754 DOI: 10.1038/srep00241  0.068
2015 Chung R, Morgan RA. Type 2 Endoleaks Post-EVAR: Current Evidence for Rupture Risk, Intervention and Outcomes of Treatment. Cardiovascular and Interventional Radiology. 38: 507-22. PMID 25189665 DOI: 10.1007/s00270-014-0987-x  0.068
2024 Ghadirian N, Morgan RD, Horton NC. DNA Sequence Control of Enzyme Filamentation and Activation of the SgrAI Endonuclease. Biochemistry. PMID 38207281 DOI: 10.1021/acs.biochem.3c00313  0.068
2012 Morgan RD, O'Callaghan JM, Knight SR, Morris PJ. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Transplantation. 93: 1179-88. PMID 22660659 DOI: 10.1097/TP.0b013e318257ad41  0.068
2014 Andreadaki M, Morgan RN, Deligianni E, Kooij TW, Santos JM, Spanos L, Matuschewski K, Louis C, Mair GR, Siden-Kiamos I. Genetic crosses and complementation reveal essential functions for the Plasmodium stage-specific actin2 in sporogonic development. Cellular Microbiology. 16: 751-67. PMID 24471657 DOI: 10.1111/cmi.12274  0.068
2010 Horwood J, Akbar F, Davis K, Morgan R. Prospective evaluation of a selective approach to cholangiography for suspected common bile duct stones. Annals of the Royal College of Surgeons of England. 92: 206-10. PMID 20223077 DOI: 10.1308/003588410X12628812458293  0.068
2013 Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological Sciences : An Official Journal of the Society of Toxicology. 136: 216-41. PMID 23956101 DOI: 10.1093/toxsci/kft176  0.068
2015 Leong L, Mendelsohn M, Saavedra C, Morgan RJ. Quality improvement education for venous thromboembolism (VTE) prevention in cancer. The Journal of Continuing Education in the Health Professions. 35: S29-30. PMID 26115240 DOI: 10.1002/chp.21287  0.067
2011 Lefemine V, Morgan RJ. Spontaneous passage of common bile duct stones in jaundiced patients. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 10: 209-13. PMID 21459730  0.067
2021 Shen BW, Quispe JD, Luyten Y, McGough BE, Morgan RD, Stoddard BL. Coordination of phage genome degradation versus host genome protection by a bifunctional restriction-modification enzyme visualized by CryoEM. Structure (London, England : 1993). PMID 33826880 DOI: 10.1016/j.str.2021.03.012  0.067
2015 Loy A, Morgan R, O'Dea S, Daly C, Mulcahy F. Clinically significant extra-cardiac findings in asymptomatic HIV-positive men undergoing cardiac magnetic resonance imaging. International Journal of Std & Aids. 26: 346-51. PMID 24872375 DOI: 10.1177/0956462414538005  0.066
2021 Zaworski J, Dagva O, Kingston AW, Fomenkov A, Morgan RD, Bossi L, Raleigh EA. Genome archaeology of two laboratory Salmonella enterica enterica sv Typhimurium. G3 (Bethesda, Md.). 11. PMID 34544129 DOI: 10.1093/g3journal/jkab226  0.066
2015 Reilly SM, Morgan RK, Brooks TA, Wadkins RM. Effect of interior loop length on the thermal stability and pK(a) of i-motif DNA. Biochemistry. 54: 1364-70. PMID 25619229 DOI: 10.1021/Bi5014722  0.066
2012 Morgan RD, Flora DB, Kroner DG, Mills JF, Varghese F, Steffan JS. Treating offenders with mental illness: a research synthesis. Law and Human Behavior. 36: 37-50. PMID 22471384 DOI: 10.1037/H0093964  0.066
2015 Morgan RB, Kwong R. Role of Cardiac MRI in the Assessment of Cardiomyopathy. Current Treatment Options in Cardiovascular Medicine. 17: 53. PMID 26446716 DOI: 10.1007/s11936-015-0410-1  0.065
2014 Yu CY, Campbell SE, Sponseller CA, Small DS, Medlock MM, Morgan RE. Steady-state pharmacokinetics of darunavir/ritonavir and pitavastatin when co-administered to healthy adult volunteers. Clinical Drug Investigation. 34: 475-82. PMID 24825411 DOI: 10.1007/s40261-014-0198-x  0.064
2012 Morgan RM, Cui C, Digges KH, Cao L, Kan CD. Impact and injury patterns in between-rails frontal crashes of vehicles with good ratings for frontal crash protection. Annals of Advances in Automotive Medicine / Annual Scientific Conference ... Association For the Advancement of Automotive Medicine. Association For the Advancement of Automotive Medicine. Scientific Conference. 56: 255-65. PMID 23169135  0.064
2021 Zaworski J, Guichard A, Fomenkov A, Morgan RD, Raleigh EA. Complete Annotated Genome Sequence of the Salmonella enterica Serovar Typhimurium LT7 Strain STK003, Historically Used in Gene Transfer Studies. Microbiology Resource Announcements. 10. PMID 33707333 DOI: 10.1128/MRA.01217-20  0.064
2014 Krebes J, Morgan RD, Bunk B, Spröer C, Luong K, Parusel R, Anton BP, König C, Josenhans C, Overmann J, Roberts RJ, Korlach J, Suerbaum S. The complex methylome of the human gastric pathogen Helicobacter pylori. Nucleic Acids Research. 42: 2415-32. PMID 24302578 DOI: 10.1093/Nar/Gkt1201  0.064
2019 Anton BP, Morgan RD, Ezraty B, Manta B, Barras F, Berkmen M. Complete Genome Sequence of Escherichia coli BE104, an MC4100 Derivative Lacking the Methionine Reductive Pathway. Microbiology Resource Announcements. 8. PMID 31296691 DOI: 10.1128/MRA.00721-19  0.064
2010 Scullion P, Morgan RM, Mohan P, Kan CD, Shanks K, Jin W, Tangirala R. A reexamination of the small overlap frontal crash. Annals of Advances in Automotive Medicine / Annual Scientific Conference ... Association For the Advancement of Automotive Medicine. Association For the Advancement of Automotive Medicine. Scientific Conference. 54: 137-48. PMID 21050598  0.064
2014 Batastini AB, Bolanos AD, Morgan RD. Attitudes toward hiring applicants with mental illness and criminal justice involvement: the impact of education and experience. International Journal of Law and Psychiatry. 37: 524-33. PMID 24629567 DOI: 10.1016/j.ijlp.2014.02.025  0.063
2020 Farooqi FI, Morgan RC, Dhawan N, Dinh J, Yatzkan G, Michel G. Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees. The American Journal of Case Reports. 21: e926596. PMID 32810081 DOI: 10.12659/AJCR.926596  0.063
2024 Rahimibarghani S, Morgan R, Diaz JJ. Neuromodulation Techniques in Chronic Refractory Coccydynia: A Narrative Review. Pain and Therapy. PMID 38175492 DOI: 10.1007/s40122-023-00572-4  0.063
2012 Morgan RA. Human tumor xenografts: the good, the bad, and the ugly. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 882-4. PMID 22549804 DOI: 10.1038/mt.2012.73  0.063
2013 Matthews JD, Morgan R, Sleigher C, Frey TK. Do viruses require the cytoskeleton? Virology Journal. 10: 121. PMID 23597412 DOI: 10.1186/1743-422X-10-121  0.063
2014 Morgan RM, Flynn J, Sena V, Bull PA. Experimental forensic studies of the preservation of pollen in vehicle fires. Science & Justice : Journal of the Forensic Science Society. 54: 141-5. PMID 24630324 DOI: 10.1016/j.scijus.2013.04.001  0.062
2022 Persaud T, Morgan R, Thant HL, DeAsis FJ, Ferre F, Diaz J. Adalimumab Mitigates Lumbar Radiculopathy in a Case of Ankylosing Spondylitis. The American Journal of Case Reports. 23: e936600. PMID 35776690 DOI: 10.12659/AJCR.936600  0.062
2016 Rooney AA, Cooper GS, Jahnke GD, Lam J, Morgan RL, Boyles AL, Ratcliffe JM, Kraft AD, Schünemann HJ, Schwingl P, Walker TD, Thayer KA, Lunn RM. How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards. Environment International. PMID 26857180 DOI: 10.1016/J.Envint.2016.01.005  0.062
2014 Scott KR, Morgan RM, Jones VJ, Cameron NG. The transferability of diatoms to clothing and the methods appropriate for their collection and analysis in forensic geoscience. Forensic Science International. 241: 127-37. PMID 24915452 DOI: 10.1016/j.forsciint.2014.05.011  0.062
2015 McGrath SE, Michael A, Morgan R, Pandha H. EN2 in Prostate Cancer Advances in Clinical Chemistry. DOI: 10.1016/bs.acc.2015.06.002  0.062
2012 Linder SK, Swank PR, Vernon SW, Morgan RO, Mullen PD, Volk RJ. Is a prostate cancer screening anxiety measure invariant across two different samples of age-appropriate men? Bmc Medical Informatics and Decision Making. 12: 52. PMID 22681782 DOI: 10.1186/1472-6947-12-52  0.062
2014 Xie Y, Morgan R, Schiff L, Hannah D, Wheless J. A computerized standard protocol order entry for pediatric inpatient acute seizure emergencies reduces time to treatment. Journal of Child Neurology. 29: 162-6. PMID 23392562 DOI: 10.1177/0883073812474950  0.061
2003 Wahlfors J, Morgan RA. Minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Production and use. Methods in Molecular Medicine. 69: 173-86. PMID 11987777 DOI: 10.1385/1-59259-141-8:173  0.061
2015 Rivas-Coppola MS, Shah N, Choudhri AF, Morgan R, Wheless JW. Chronological Evolution of Magnetic Resonance Imaging Findings in Children With Febrile Infection-Related Epilepsy Syndrome. Pediatric Neurology. PMID 26597039 DOI: 10.1016/J.Pediatrneurol.2015.09.003  0.061
2015 Rahbar MH, Samms-Vaughan M, Dickerson AS, Hessabi M, Bressler J, Desai CC, Shakespeare-Pellington S, Reece JA, Morgan R, Loveland KA, Grove ML, Boerwinkle E. Concentration of lead, mercury, cadmium, aluminum, arsenic and manganese in umbilical cord blood of Jamaican newborns. International Journal of Environmental Research and Public Health. 12: 4481-501. PMID 25915835 DOI: 10.3390/Ijerph120504481  0.061
2012 Nordon IM, Hinchliffe RJ, Morgan R, Loftus IM, Jahangiri M, Thompson MM. Progress in endovascular management of type A dissection. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 44: 406-10. PMID 22921418 DOI: 10.1016/j.ejvs.2012.07.018  0.061
2015 Whited WH, Wagar L, Mandracchia JT, Morgan RD. Partners or Partners in Crime? The Relationship Between Criminal Associates and Criminogenic Thinking. International Journal of Offender Therapy and Comparative Criminology. PMID 26320107 DOI: 10.1177/0306624X15599605  0.061
2012 Xu SY, Nugent RL, Kasamkattil J, Fomenkov A, Gupta Y, Aggarwal A, Wang X, Li Z, Zheng Y, Morgan R. Characterization of type II and III restriction-modification systems from Bacillus cereus strains ATCC 10987 and ATCC 14579. Journal of Bacteriology. 194: 49-60. PMID 22037402 DOI: 10.1128/Jb.06248-11  0.06
2015 Morgan R, Keen J, McGowan C. Equine metabolic syndrome. The Veterinary Record. 177: 173-9. PMID 26273009 DOI: 10.1136/vr.103226  0.06
2014 Godwin KM, Morgan RO, Walder A, Bass DM, Judge KS, Wilson N, Snow AL, Kunik ME. Predictors of Inpatient Utilization among Veterans with Dementia. Current Gerontology and Geriatrics Research. 2014: 861613. PMID 24982674 DOI: 10.1155/2014/861613  0.06
2013 Chun JY, Morgan R. Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 45: 141-4. PMID 23276679 DOI: 10.1016/j.ejvs.2012.11.010  0.059
2015 Destounis SV, Morgan R, Arieno A. Screening for dense breasts: digital breast tomosynthesis. Ajr. American Journal of Roentgenology. 204: 261-4. PMID 25615747 DOI: 10.2214/AJR.14.13554  0.059
2008 Morgan RD, Bhatia TK, Lovasco L, Davis TB. MmeI: a minimal Type II restriction-modification system that only modifies one DNA strand for host protection. Nucleic Acids Research. 36: 6558-70. PMID 18931376 DOI: 10.1093/Nar/Gkn711  0.059
2014 Bentler SE, Morgan RO, Virnig BA, Wolinsky FD. Do claims-based continuity of care measures reflect the patient perspective? Medical Care Research and Review : McRr. 71: 156-73. PMID 24163307 DOI: 10.1177/1077558713505909  0.059
2012 van Staden CJ, Morgan RE, Ramachandran B, Chen Y, Lee PH, Hamadeh HK. Membrane vesicle ABC transporter assays for drug safety assessment. Current Protocols in Toxicology / Editorial Board, Mahin D. Maines (Editor-in-Chief) ... [Et Al.]. Unit 23.5. PMID 23169270 DOI: 10.1002/0471140856.tx2305s54  0.058
2013 Morgan RO, Sail KR, Snow AL, Davila JA, Fouladi NN, Kunik ME. Modeling causes of aggressive behavior in patients with dementia. The Gerontologist. 53: 738-47. PMID 23103521 DOI: 10.1093/Geront/Gns129  0.058
2006 Shah CS, Hardy WN, Mason MJ, Yang KH, Van Ee CA, Morgan R, Digges K. Dynamic biaxial tissue properties of the human cadaver aorta. Stapp Car Crash Journal. 50: 217-46. PMID 17311166 DOI: 10.4271/2006-22-0010  0.058
2013 Anton BP, Chang YC, Brown P, Choi HP, Faller LL, Guleria J, Hu Z, Klitgord N, Levy-Moonshine A, Maksad A, Mazumdar V, McGettrick M, Osmani L, Pokrzywa R, Rachlin J, ... ... Morgan RD, et al. The COMBREX project: design, methodology, and initial results. Plos Biology. 11: e1001638. PMID 24013487 DOI: 10.1371/Journal.Pbio.1001638  0.057
2012 O'Callaghan JM, Knight SR, Morgan RD, Morris PJ. Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 896-906. PMID 22221739 DOI: 10.1111/j.1600-6143.2011.03908.x  0.057
2013 Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Du XL. Utilization of lymph node dissection, race/ethnicity, and breast cancer outcomes. The American Journal of Managed Care. 19: 805-10. PMID 24304159  0.057
2015 Morgan RE, Chudasama V, Moody P, Smith ME, Caddick S. A novel synthetic chemistry approach to linkage-specific ubiquitin conjugation. Organic & Biomolecular Chemistry. 13: 4165-8. PMID 25736233 DOI: 10.1039/c5ob00130g  0.056
2014 Morgan RA. Boolean immunotherapy: reversal of fortune. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1073-4. PMID 24881766 DOI: 10.1038/mt.2014.75  0.056
2014 Bentler SE, Morgan RO, Virnig BA, Wolinsky FD. The association of longitudinal and interpersonal continuity of care with emergency department use, hospitalization, and mortality among Medicare beneficiaries. Plos One. 9: e115088. PMID 25531108 DOI: 10.1371/Journal.Pone.0115088  0.056
2013 Kirk M, Tonkin E, Skirton H, McDonald K, Cope B, Morgan R. Storytellers as partners in developing a genetics education resource for health professionals. Nurse Education Today. 33: 518-24. PMID 22197414 DOI: 10.1016/j.nedt.2011.11.019  0.056
2012 Morgan RM, Hernández-Ramírez LC, Trivellin G, Zhou L, Roe SM, Korbonits M, Prodromou C. Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition. Plos One. 7: e53339. PMID 23300914 DOI: 10.1371/journal.pone.0053339  0.056
2013 Wolff N, Frueh BC, Huening J, Shi J, Epperson MW, Morgan R, Fisher W. Practice informs the next generation of behavioral health and criminal justice interventions. International Journal of Law and Psychiatry. 36: 1-10. PMID 23182402 DOI: 10.1016/J.Ijlp.2012.11.001  0.056
2014 Miles HF, Morgan RM, Millington JE. The influence of fabric surface characteristics on satellite bloodstain morphology. Science & Justice : Journal of the Forensic Science Society. 54: 262-6. PMID 25002043 DOI: 10.1016/j.scijus.2014.04.002  0.055
2014 Audu B, Morgan R, Rutter P. Qualitative exploration of the relationship between HIV/AIDS patients' experiences of clinical services and treatment adherence at Maitama District Hospital, Abuja, Nigeria. Aids Care. 26: 270-3. PMID 23875980 DOI: 10.1080/09540121.2013.819410  0.055
2016 Oldekop JA, Fontana LB, Grugel J, Roughton N, Adu-Ampong EA, Bird GK, Dorgan A, Vera Espinoza MA, Wallin S, Hammett D, Agbarakwe E, Agrawal A, Asylbekova N, Azkoul C, Bardsley C, ... ... Morgan RJ, et al. 100 key research questions for the post-2015 development agenda Development Policy Review. 34: 55-82. DOI: 10.1111/Dpr.12147  0.055
2013 Ghatwary TM, Patterson BO, Karthikesalingam A, Hinchliffe RJ, Loftus IM, Morgan R, Thompson MM, Holt PJ. A systematic review of protocols for the three-dimensional morphologic assessment of abdominal aortic aneurysms using computed tomographic angiography. Cardiovascular and Interventional Radiology. 36: 14-24. PMID 22159906 DOI: 10.1007/s00270-011-0296-6  0.055
2014 Bass DM, Judge KS, Snow AL, Wilson NL, Morgan RO, Maslow K, Randazzo R, Moye JA, Odenheimer GL, Archambault E, Elbein R, Pirraglia P, Teasdale TA, McCarthy CA, Looman WJ, et al. A controlled trial of Partners in Dementia Care: veteran outcomes after six and twelve months. Alzheimer's Research & Therapy. 6: 9. PMID 24764496 DOI: 10.1186/Alzrt242  0.054
2011 Joseph HA, Fasula AM, Morgan RL, Stuckey A, Alvarez ME, Margolis A, Stratford D, Dooley SW. "The anticipation alone could kill you": past and potential clients' perspectives on HIV testing in non-health care settings. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 23: 577-94. PMID 22201240 DOI: 10.1521/aeap.2011.23.6.577  0.054
2015 Goodman ML, Selwyn BJ, Morgan RO, Lloyd LE, Mwongera M, Gitari S, Keiser PH. Sexual Behavior Among Young Carers in the Context of a Kenyan Empowerment Program Combining Cash-Transfer, Psychosocial Support, and Entrepreneurship. Journal of Sex Research. 1-15. PMID 26421980 DOI: 10.1080/00224499.2015.1035429  0.054
2015 Morgan RM, Pal M, Roe SM, Pearl LH, Prodromou C. Tah1 helix-swap dimerization prevents mixed Hsp90 co-chaperone complexes. Acta Crystallographica. Section D, Biological Crystallography. 71: 1197-206. PMID 25945584 DOI: 10.1107/S1399004715004551  0.054
2015 Batastini AB, King CM, Morgan RD, McDaniel B. Telepsychological Services With Criminal Justice and Substance Abuse Clients: A Systematic Review and Meta-Analysis. Psychological Services. PMID 26192259 DOI: 10.1037/ser0000042  0.054
2015 Kazyak DC, Hilderbrand RH, Keller SR, Colaw MC, Holloway AE, Morgan RP, King TL. Spatial Structure of Morphological and Neutral Genetic Variation in Brook Trout Transactions of the American Fisheries Society. 144: 480-490. DOI: 10.1080/00028487.2015.1012300  0.054
2015 Aspinall EJ, Doyle JS, Corson S, Hellard ME, Hunt D, Goldberg D, Nguyen T, Falck-Ytter Y, Morgan RL, Smith B, Stoove M, Wiktor SZ, Hutchinson S. Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis. European Journal of Epidemiology. 30: 115-29. PMID 25385677 DOI: 10.1007/s10654-014-9958-4  0.054
2015 Destounis S, Arieno A, Morgan R. Personal History of Premenopausal Breast Cancer as a Risk Factor for Referral to Screening Breast MRI Academic Radiology. DOI: 10.1016/j.acra.2015.11.012  0.054
2008 Hardy WN, Shah CS, Mason MJ, Kopacz JM, Yang KH, King AI, Van Ee CA, Bishop JL, Banglmaier RF, Bey MJ, Morgan RM, Digges KH. Mechanisms of traumatic rupture of the aorta and associated peri-isthmic motion and deformation. Stapp Car Crash Journal. 52: 233-65. PMID 19085165 DOI: 10.4271/2008-22-0010  0.053
2013 Deligianni E, Morgan RN, Bertuccini L, Wirth CC, Silmon de Monerri NC, Spanos L, Blackman MJ, Louis C, Pradel G, Siden-Kiamos I. A perforin-like protein mediates disruption of the erythrocyte membrane during egress of Plasmodium berghei male gametocytes. Cellular Microbiology. 15: 1438-55. PMID 23461714 DOI: 10.1111/cmi.12131  0.053
2012 Metcalfe MJ, Karthikesalingam A, Black SA, Loftus IM, Morgan R, Thompson MM. The first endovascular repair of an acute type A dissection using an endograft designed for the ascending aorta. Journal of Vascular Surgery. 55: 220-2. PMID 21908151 DOI: 10.1016/j.jvs.2011.06.116  0.053
2014 Morgan RM, Allen E, King T, Bull PA. The spatial and temporal distribution of pollen in a room: forensic implications. Science & Justice : Journal of the Forensic Science Society. 54: 49-56. PMID 24438777 DOI: 10.1016/j.scijus.2013.03.005  0.053
2008 Blum JJ, Scullion P, Morgan RM, Digges K, Kan CD, Park S, Bae H. Vehicle related factors that influence injury outcome in head-on collisions. Annals of Advances in Automotive Medicine / Annual Scientific Conference ... Association For the Advancement of Automotive Medicine. Association For the Advancement of Automotive Medicine. Scientific Conference. 52: 131-40. PMID 19026230  0.053
2015 Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, ... ... Morgan RL, et al. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 17: 63-7. PMID 24946156 DOI: 10.1038/Gim.2014.69  0.053
Hide low-probability matches.